<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://m2.mtmt.hu/xsl/gui3.xsl" ?>
<myciteResult>
  <serverUrl>https://m2.mtmt.hu/</serverUrl>
  <labelLang>eng</labelLang>
  <responseDate>2026-04-16 10:52</responseDate>
  <content>
    <publication>
      <otype>JournalArticle</otype>
      <mtid>34093130</mtid>
      <status>VALIDATED</status>
      <published>true</published>
      <comment>Department of Lab, Chifeng Cancer Hospital (The 2nd Affliated Hospital of Chifeng University), Chifeng University, Inner Mongolia Autonomous Region, Chifeng City, 024000, China            
            Department of General Surgery and Institute of Precision Diagnosis and Treatment of Digestive System Tumors, Carson International Cancer Center, Shenzhen University General Hospital, Shenzhen University, Guangdong, Shenzhen, 518055, China            
            Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, Shanghai, 200032, China            
            Molecular Medicine Research Line, Fondazione Istituto Italiano di Tecnologia (IIT), Genoa, 16163, Italy            
            Cancer Research Group-School of Life Health and Chemical Sciences, The Open University, Milton Keynes, United Kingdom            
            Department of Bioinformatics, Semmelweis University, Tüzoltó u. 7-9, Budapest, 1094, Hungary            
            Life Sciences Institute and Department of Molecular, Cellular and Developmental Biology, University of Michigan, Ann Arbor, MI, United States            
            Shanghai Institute of Cardiovascular Diseases, Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai, 200032, China            
            Department of Pediatrics, Semmelweis University, Tüzoltó u. 7-9, Budapest, 1094, Hungary            
            Cancer Biomarker Research Group, Institute of Molecular Life Sciences, Research Centre for Natural Sciences, Magyar tudosok korutja 2, Budapest, 1117, Hungary            
            Cited By :16            
            Export Date: 6 February 2024            
            CODEN: CALED            
            Correspondence Address: Ashrafizadeh, M.; Department of General Surgery and Institute of Precision Diagnosis and Treatment of Digestive System Tumors, Guangdong, China; email: dvm.milad1994@gmail.com            
            Correspondence Address: Qin, Y.; Department of Lab, Inner Mongolia Autonomous Region, China; email: qinyimedicine001@163.com            
            Correspondence Address: Zhang, X.; Department of General Surgery and Institute of Precision Diagnosis and Treatment of Digestive System Tumors, Guangdong, China; email: xianbin.zhang@szu.edu.cn            
            Chemicals/CAS: 2 morpholino 8 phenylchromone, 154447-36-6; chloroquine, 132-73-0, 3545-67-3, 50-63-5, 54-05-7, 1446-17-9; cisplatin, 15663-27-1, 26035-31-4, 96081-74-2; doxorubicin, 23214-92-8, 25316-40-9; gefitinib, 184475-35-2, 184475-55-6, 184475-56-7; hydroxymethylglutaryl coenzyme A reductase kinase, 172522-01-9, 72060-32-3; lapatinib, 231277-92-2, 388082-78-8, 437755-78-7; mitogen activated protein kinase, 142243-02-5; paclitaxel, 33069-62-4; phosphatidylinositol 3 kinase, 115926-52-8; protein kinase B, 148640-14-6; pseudolaric acid B, 82508-31-4; sorafenib, 284461-73-0, 475207-59-1; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases            
            Tradenames: ly 294002            
            Funding text 1: The schematic representation was generated using biorender software (biorender.com).</comment>
      <unhandledTickets>0</unhandledTickets>
      <deleted>false</deleted>
      <lastRefresh>2026-03-25T17:55:41.859+0000</lastRefresh>
      <lastModified>2023-09-28T11:48:30.617+0000</lastModified>
      <created>2023-08-11T09:04:40.953+0000</created>
      <creator>
        <snippet>true</snippet>
        <mtid>10062250</mtid>
        <familyName>Molnár-Taga</familyName>
        <givenName>Márta</givenName>
        <link>/api/admin/10062250</link>
        <otype>Admin</otype>
        <label>Márta Molnár-Taga (SE 4-es admin)</label>
        <published>true</published>
        <oldId>10062250</oldId>
      </creator>
      <lastDuplumSearch>2025-05-12T17:12:55.693+0000</lastDuplumSearch>
      <validated>2023-09-15T09:45:02.056+0000</validated>
      <validator>
        <snippet>true</snippet>
        <mtid>10080205</mtid>
        <familyName>Szalóky-Siki</familyName>
        <givenName>Ágnes</givenName>
        <link>/api/admin/10080205</link>
        <otype>Admin</otype>
        <label>Ágnes Szalóky-Siki (SE_KK_Admin5_SZSA, admin)</label>
        <published>true</published>
      </validator>
      <tempLockers>
        <otype>Admin</otype>
        <mtid>10014568</mtid>
        <link>/api/admin/10014568</link>
        <label>Andrea Vándor (VA, admin)</label>
        <familyName>Vándor</familyName>
        <givenName>Andrea</givenName>
        <published>true</published>
        <oldId>10014568</oldId>
        <snippet>true</snippet>
      </tempLockers>
      <tempLocked>2024-04-04T10:41:47.408+0000</tempLocked>
      <core>true</core>
      <publicationPending>false</publicationPending>
      <type>
        <snippet>true</snippet>
        <mtid>24</mtid>
        <code>24</code>
        <link>/api/publicationtype/24</link>
        <otype>PublicationType</otype>
        <label>Journal Article</label>
        <listPosition>1</listPosition>
        <published>true</published>
        <oldId>24</oldId>
        <otypeName>JournalArticle</otypeName>
      </type>
      <subType>
        <snippet>true</snippet>
        <mtid>10000059</mtid>
        <nameEng>Article</nameEng>
        <docType>
          <snippet>true</snippet>
          <mtid>24</mtid>
          <code>24</code>
          <link>/api/publicationtype/24</link>
          <otype>PublicationType</otype>
          <label>Journal Article</label>
          <listPosition>1</listPosition>
          <published>true</published>
          <oldId>24</oldId>
          <otypeName>JournalArticle</otypeName>
        </docType>
        <link>/api/subtype/10000059</link>
        <name>Szakcikk</name>
        <otype>SubType</otype>
        <label>Article (Journal Article)</label>
        <listPosition>101</listPosition>
        <published>true</published>
        <oldId>10000059</oldId>
      </subType>
      <category>
        <snippet>true</snippet>
        <mtid>1</mtid>
        <link>/api/category/1</link>
        <otype>Category</otype>
        <label>Scientific</label>
        <published>true</published>
        <oldId>1</oldId>
      </category>
      <firstAuthor>Qin, Y.</firstAuthor>
      <title>Autophagy and cancer drug resistance in dialogue: Pre-clinical and clinical evidence</title>
      <journal>
        <snippet>true</snippet>
        <sciIndexed>true</sciIndexed>
        <link>/api/journal/910</link>
        <reviewType>REVIEWED</reviewType>
        <label>CANCER LETTERS 0304-3835 1872-7980</label>
        <published>true</published>
        <hungarian>false</hungarian>
        <oldId>910</oldId>
        <noIF>false</noIF>
        <mtid>910</mtid>
        <scopusIndexed>true</scopusIndexed>
        <pIssn>0304-3835</pIssn>
        <eIssn>1872-7980</eIssn>
        <otype>Journal</otype>
        <lang>FOREIGN</lang>
      </journal>
      <volume>570</volume>
      <internalId>216307</internalId>
      <firstPageOrInternalIdForSort>216307</firstPageOrInternalIdForSort>
      <pageLength>15</pageLength>
      <publishedYear>2023</publishedYear>
      <abstractText>The emergence of drug resistance is a major challenge for oncologists. Resistance can be categorized as acquired or intrinsic; the alteration of several biological mechanisms contributes to both intrinsic and acquired resistance. Macroautophagy/autophagy is the primary process in eukaryotes for the degradation of macromolecules and organelles. This process is critical in maintaining cellular homeostasis. Given its function as either a pro-survival or a pro-death phenomenon, autophagy has a complex physio-pathological role. In some circumstances, autophagy can confer chemoresistance and promote cell survival, whereas in others it can promote chemosensitivity and contribute to cell death. The role of autophagy in the modulation of cancer drug resistance reflects its impact on apoptosis and metastasis. The regulation of autophagy in cancer is mediated by various factors including AMP-activated protein kinase (AMPK), MAPK, phosphoinositide 3-kinase (PI3K)-AKT, BECN1 and ATG proteins. Non-coding RNAs are among the main regulators of autophagy, e.g., via the modulation of chemoresistance pathways. Due to the significant contribution of autophagy in cancer drug resistance, small molecule modulators and natural compounds targeting autophagy have been introduced to alter the response of cancer cells to chemotherapy. Furthermore, nanotherapeutic approaches based on autophagy regulation have been introduced in pre-clinical cancer therapy. In this review we consider the potential for using autophagy regulators for the clinical treatment of malignancies. © 2023 Elsevier B.V.</abstractText>
      <digital>true</digital>
      <printed>true</printed>
      <sourceYear>2023</sourceYear>
      <foreignEdition>true</foreignEdition>
      <foreignLanguage>true</foreignLanguage>
      <fullPublication>true</fullPublication>
      <conferencePublication>false</conferencePublication>
      <nationalOrigin>true</nationalOrigin>
      <missingAuthor>false</missingAuthor>
      <oaType>PAY</oaType>
      <oaCheckDate>2026-03-25</oaCheckDate>
      <oaFree>false</oaFree>
      <citationCount>195</citationCount>
      <citationCountUnpublished>0</citationCountUnpublished>
      <citationCountWoOther>195</citationCountWoOther>
      <independentCitCountWoOther>174</independentCitCountWoOther>
      <nationalOriginCitationCount>1</nationalOriginCitationCount>
      <foreignEditionCitationCount>195</foreignEditionCitationCount>
      <doiCitationCount>194</doiCitationCount>
      <wosCitationCount>177</wosCitationCount>
      <scopusCitationCount>177</scopusCitationCount>
      <wosScopusCitationCount>195</wosScopusCitationCount>
      <wosScopusCitationCountWoOther>195</wosScopusCitationCountWoOther>
      <wosScopusIndependentCitationCount>174</wosScopusIndependentCitationCount>
      <wosScopusIndependentCitationCountWoOther>174</wosScopusIndependentCitationCountWoOther>
      <independentCitationCount>174</independentCitationCount>
      <selfCitationCount>21</selfCitationCount>
      <unhandledCitationCount>0</unhandledCitationCount>
      <citingPubCount>195</citingPubCount>
      <independentCitingPubCount>174</independentCitingPubCount>
      <citingPubCountWoOther>195</citingPubCountWoOther>
      <independentCitingPubCountWoOther>174</independentCitingPubCountWoOther>
      <unhandledCitingPubCount>0</unhandledCitingPubCount>
      <citedPubCount>4</citedPubCount>
      <citedCount>4</citedCount>
      <pubStats>
        <types>
          <type>Folyóiratcikk</type>
          <typeEng>Journal Article</typeEng>
          <code>24</code>
          <count>180</count>
        </types>
        <types>
          <type>Könyvrészlet</type>
          <typeEng>Chapter in Book</typeEng>
          <code>25</code>
          <count>15</count>
        </types>
        <types>
          <type>Könyv</type>
          <typeEng>Book</typeEng>
          <code>23</code>
          <count>0</count>
        </types>
        <types>
          <type>Egyéb konferenciaközlemény</type>
          <typeEng>Conference paper</typeEng>
          <code>31</code>
          <count>0</count>
        </types>
        <types>
          <type>Egyéb konferenciakötet</type>
          <typeEng>Conference proceedings</typeEng>
          <code>32</code>
          <count>0</count>
        </types>
        <types>
          <type>Oltalmi formák</type>
          <typeEng>Protection forms</typeEng>
          <code>26</code>
          <count>0</count>
        </types>
        <types>
          <type>Disszertáció</type>
          <typeEng>Thesis</typeEng>
          <code>28</code>
          <count>0</count>
        </types>
        <types>
          <type>Egyéb</type>
          <typeEng>Miscellaneous</typeEng>
          <code>29</code>
          <count>0</count>
        </types>
        <types>
          <type>Alkotás</type>
          <typeEng>Achievement</typeEng>
          <code>22</code>
          <count>0</count>
        </types>
        <types>
          <type>Kutatási adat</type>
          <typeEng>Research data</typeEng>
          <code>33</code>
          <count>0</count>
        </types>
        <citationTypes>
          <type>Folyóiratcikk</type>
          <typeEng>Journal Article</typeEng>
          <code>24</code>
          <countUnknown>0</countUnknown>
          <countIndependent>0</countIndependent>
          <countSelfCitation>0</countSelfCitation>
        </citationTypes>
        <citationTypes>
          <type>Könyvrészlet</type>
          <typeEng>Chapter in Book</typeEng>
          <code>25</code>
          <countUnknown>0</countUnknown>
          <countIndependent>0</countIndependent>
          <countSelfCitation>0</countSelfCitation>
        </citationTypes>
        <citationTypes>
          <type>Könyv</type>
          <typeEng>Book</typeEng>
          <code>23</code>
          <countUnknown>0</countUnknown>
          <countIndependent>0</countIndependent>
          <countSelfCitation>0</countSelfCitation>
        </citationTypes>
        <citationTypes>
          <type>Egyéb konferenciaközlemény</type>
          <typeEng>Conference paper</typeEng>
          <code>31</code>
          <countUnknown>0</countUnknown>
          <countIndependent>0</countIndependent>
          <countSelfCitation>0</countSelfCitation>
        </citationTypes>
        <citationTypes>
          <type>Egyéb konferenciakötet</type>
          <typeEng>Conference proceedings</typeEng>
          <code>32</code>
          <countUnknown>0</countUnknown>
          <countIndependent>0</countIndependent>
          <countSelfCitation>0</countSelfCitation>
        </citationTypes>
        <citationTypes>
          <type>Oltalmi formák</type>
          <typeEng>Protection forms</typeEng>
          <code>26</code>
          <countUnknown>0</countUnknown>
          <countIndependent>0</countIndependent>
          <countSelfCitation>0</countSelfCitation>
        </citationTypes>
        <citationTypes>
          <type>Disszertáció</type>
          <typeEng>Thesis</typeEng>
          <code>28</code>
          <countUnknown>0</countUnknown>
          <countIndependent>0</countIndependent>
          <countSelfCitation>0</countSelfCitation>
        </citationTypes>
        <citationTypes>
          <type>Egyéb</type>
          <typeEng>Miscellaneous</typeEng>
          <code>29</code>
          <countUnknown>0</countUnknown>
          <countIndependent>0</countIndependent>
          <countSelfCitation>0</countSelfCitation>
        </citationTypes>
        <citationTypes>
          <type>Alkotás</type>
          <typeEng>Achievement</typeEng>
          <code>22</code>
          <countUnknown>0</countUnknown>
          <countIndependent>0</countIndependent>
          <countSelfCitation>0</countSelfCitation>
        </citationTypes>
        <citationTypes>
          <type>Kutatási adat</type>
          <typeEng>Research data</typeEng>
          <code>33</code>
          <countUnknown>0</countUnknown>
          <countIndependent>0</countIndependent>
          <countSelfCitation>0</countSelfCitation>
        </citationTypes>
        <years>
          <year>2023</year>
          <publicationCount>0</publicationCount>
          <citationCount>7</citationCount>
          <independentCitationCount>6</independentCitationCount>
          <citingPubCount>7</citingPubCount>
          <independentCitingPubCount>6</independentCitingPubCount>
          <oaStats/>
          <oaStats2/>
        </years>
        <years>
          <year>2024</year>
          <publicationCount>0</publicationCount>
          <citationCount>110</citationCount>
          <independentCitationCount>93</independentCitationCount>
          <citingPubCount>110</citingPubCount>
          <independentCitingPubCount>93</independentCitingPubCount>
          <oaStats/>
          <oaStats2/>
        </years>
        <years>
          <year>2025</year>
          <publicationCount>0</publicationCount>
          <citationCount>75</citationCount>
          <independentCitationCount>72</independentCitationCount>
          <citingPubCount>75</citingPubCount>
          <independentCitingPubCount>72</independentCitingPubCount>
          <oaStats/>
          <oaStats2/>
        </years>
        <years>
          <year>2026</year>
          <publicationCount>0</publicationCount>
          <citationCount>3</citationCount>
          <independentCitationCount>3</independentCitationCount>
          <citingPubCount>3</citingPubCount>
          <independentCitingPubCount>3</independentCitingPubCount>
          <oaStats/>
          <oaStats2/>
        </years>
      </pubStats>
      <ratingsForSort>D1</ratingsForSort>
      <hasCitationDuplums>false</hasCitationDuplums>
      <importDuplum>false</importDuplum>
      <importOverwritten>false</importOverwritten>
      <importSkipped>false</importSkipped>
      <userChangeableUntil>2023-08-17T08:45:51.059+0000</userChangeableUntil>
      <directInstitutesForSort>Bioinformatika Tanszék (SE / AOK / I); Gyermekgyógyászati Klinika (SE / AOK / K); Onkológiai Biomarker Kutatócsoport (Lendület) (HRN TTK / MÉI)</directInstitutesForSort>
      <ownerAuthorCount>1</ownerAuthorCount>
      <ownerInstituteCount>26</ownerInstituteCount>
      <directInstituteCount>3</directInstituteCount>
      <authorCount>11</authorCount>
      <contributorCount>0</contributorCount>
      <hasQualityFactor>true</hasQualityFactor>
      <tempLockerIds>10014568</tempLockerIds>
      <languages>
        <language>
          <otype>Language</otype>
          <mtid>10002</mtid>
          <link>/api/language/10002</link>
          <label>English</label>
          <name>Angol</name>
          <nameEng>English</nameEng>
          <published>true</published>
          <oldId>2</oldId>
          <snippet>true</snippet>
        </language>
      </languages>
      <authorships>
        <authorship>
          <otype>PersonAuthorship</otype>
          <mtid>109572204</mtid>
          <link>/api/authorship/109572204</link>
          <label>Qin, Y. ✉</label>
          <listPosition>1</listPosition>
          <share>0.09090909</share>
          <first>true</first>
          <last>false</last>
          <corresponding>true</corresponding>
          <familyName>Qin</familyName>
          <givenName>Y.</givenName>
          <authorTyped>true</authorTyped>
          <editorTyped>false</editorTyped>
          <otherTyped>false</otherTyped>
          <type>
            <otype>AuthorshipType</otype>
            <mtid>1</mtid>
            <link>/api/authorshiptype/1</link>
            <label>Author</label>
            <code>0</code>
            <published>true</published>
            <oldId>0</oldId>
            <snippet>true</snippet>
          </type>
          <published>false</published>
          <snippet>true</snippet>
        </authorship>
        <authorship>
          <otype>PersonAuthorship</otype>
          <mtid>109572205</mtid>
          <link>/api/authorship/109572205</link>
          <label>Ashrafizadeh, M. ✉</label>
          <listPosition>2</listPosition>
          <share>0.09090909</share>
          <first>false</first>
          <last>false</last>
          <corresponding>true</corresponding>
          <familyName>Ashrafizadeh</familyName>
          <givenName>M.</givenName>
          <authorTyped>true</authorTyped>
          <editorTyped>false</editorTyped>
          <otherTyped>false</otherTyped>
          <type>
            <otype>AuthorshipType</otype>
            <mtid>1</mtid>
            <link>/api/authorshiptype/1</link>
            <label>Author</label>
            <code>0</code>
            <published>true</published>
            <oldId>0</oldId>
            <snippet>true</snippet>
          </type>
          <published>false</published>
          <snippet>true</snippet>
        </authorship>
        <authorship>
          <otype>PersonAuthorship</otype>
          <mtid>109572206</mtid>
          <link>/api/authorship/109572206</link>
          <label>Mongiardini, V.</label>
          <listPosition>3</listPosition>
          <share>0.09090909</share>
          <first>false</first>
          <last>false</last>
          <corresponding>false</corresponding>
          <familyName>Mongiardini</familyName>
          <givenName>V.</givenName>
          <authorTyped>true</authorTyped>
          <editorTyped>false</editorTyped>
          <otherTyped>false</otherTyped>
          <type>
            <otype>AuthorshipType</otype>
            <mtid>1</mtid>
            <link>/api/authorshiptype/1</link>
            <label>Author</label>
            <code>0</code>
            <published>true</published>
            <oldId>0</oldId>
            <snippet>true</snippet>
          </type>
          <published>false</published>
          <snippet>true</snippet>
        </authorship>
        <authorship>
          <otype>PersonAuthorship</otype>
          <mtid>109572207</mtid>
          <link>/api/authorship/109572207</link>
          <label>Grimaldi, B.</label>
          <listPosition>4</listPosition>
          <share>0.09090909</share>
          <first>false</first>
          <last>false</last>
          <corresponding>false</corresponding>
          <familyName>Grimaldi</familyName>
          <givenName>B.</givenName>
          <authorTyped>true</authorTyped>
          <editorTyped>false</editorTyped>
          <otherTyped>false</otherTyped>
          <type>
            <otype>AuthorshipType</otype>
            <mtid>1</mtid>
            <link>/api/authorshiptype/1</link>
            <label>Author</label>
            <code>0</code>
            <published>true</published>
            <oldId>0</oldId>
            <snippet>true</snippet>
          </type>
          <published>false</published>
          <snippet>true</snippet>
        </authorship>
        <authorship>
          <otype>PersonAuthorship</otype>
          <mtid>109572208</mtid>
          <link>/api/authorship/109572208</link>
          <label>Crea, F.</label>
          <listPosition>5</listPosition>
          <share>0.09090909</share>
          <first>false</first>
          <last>false</last>
          <corresponding>false</corresponding>
          <familyName>Crea</familyName>
          <givenName>F.</givenName>
          <authorTyped>true</authorTyped>
          <editorTyped>false</editorTyped>
          <otherTyped>false</otherTyped>
          <type>
            <otype>AuthorshipType</otype>
            <mtid>1</mtid>
            <link>/api/authorshiptype/1</link>
            <label>Author</label>
            <code>0</code>
            <published>true</published>
            <oldId>0</oldId>
            <snippet>true</snippet>
          </type>
          <published>false</published>
          <snippet>true</snippet>
        </authorship>
        <authorship>
          <otype>PersonAuthorship</otype>
          <mtid>109572209</mtid>
          <link>/api/authorship/109572209</link>
          <label>Rietdorf, K.</label>
          <listPosition>6</listPosition>
          <share>0.09090909</share>
          <first>false</first>
          <last>false</last>
          <corresponding>false</corresponding>
          <familyName>Rietdorf</familyName>
          <givenName>K.</givenName>
          <authorTyped>true</authorTyped>
          <editorTyped>false</editorTyped>
          <otherTyped>false</otherTyped>
          <type>
            <otype>AuthorshipType</otype>
            <mtid>1</mtid>
            <link>/api/authorshiptype/1</link>
            <label>Author</label>
            <code>0</code>
            <published>true</published>
            <oldId>0</oldId>
            <snippet>true</snippet>
          </type>
          <published>false</published>
          <snippet>true</snippet>
        </authorship>
        <authorship>
          <otype>PersonAuthorship</otype>
          <mtid>109572210</mtid>
          <link>/api/authorship/109572210</link>
          <label>Győrffy, B. [Győrffy, Balázs (Onkológia), author] Enzim_417 (IMLS); Bioinformatika Tanszék (SU / FM / I); Department of Pediatrics (SU / FM / C)</label>
          <listPosition>7</listPosition>
          <share>0.091</share>
          <first>false</first>
          <last>false</last>
          <corresponding>false</corresponding>
          <author>
            <otype>Author</otype>
            <mtid>10000109</mtid>
            <link>/api/author/10000109</link>
            <label>Balázs Győrffy (Onkológia)</label>
            <familyName>Győrffy</familyName>
            <givenName>Balázs</givenName>
            <published>true</published>
            <oldId>10000109</oldId>
            <snippet>true</snippet>
          </author>
          <familyName>Győrffy</familyName>
          <givenName>B.</givenName>
          <authorTyped>true</authorTyped>
          <editorTyped>false</editorTyped>
          <otherTyped>false</otherTyped>
          <type>
            <otype>AuthorshipType</otype>
            <mtid>1</mtid>
            <link>/api/authorshiptype/1</link>
            <label>Author</label>
            <code>0</code>
            <published>true</published>
            <oldId>0</oldId>
            <snippet>true</snippet>
          </type>
          <published>false</published>
          <snippet>true</snippet>
        </authorship>
        <authorship>
          <otype>PersonAuthorship</otype>
          <mtid>109572211</mtid>
          <link>/api/authorship/109572211</link>
          <label>Klionsky, D.J.</label>
          <listPosition>8</listPosition>
          <share>0.09090909</share>
          <first>false</first>
          <last>false</last>
          <corresponding>false</corresponding>
          <familyName>Klionsky</familyName>
          <givenName>D.J.</givenName>
          <authorTyped>true</authorTyped>
          <editorTyped>false</editorTyped>
          <otherTyped>false</otherTyped>
          <type>
            <otype>AuthorshipType</otype>
            <mtid>1</mtid>
            <link>/api/authorshiptype/1</link>
            <label>Author</label>
            <code>0</code>
            <published>true</published>
            <oldId>0</oldId>
            <snippet>true</snippet>
          </type>
          <published>false</published>
          <snippet>true</snippet>
        </authorship>
        <authorship>
          <otype>PersonAuthorship</otype>
          <mtid>109572212</mtid>
          <link>/api/authorship/109572212</link>
          <label>Ren, J.</label>
          <listPosition>9</listPosition>
          <share>0.09090909</share>
          <first>false</first>
          <last>false</last>
          <corresponding>false</corresponding>
          <familyName>Ren</familyName>
          <givenName>J.</givenName>
          <authorTyped>true</authorTyped>
          <editorTyped>false</editorTyped>
          <otherTyped>false</otherTyped>
          <type>
            <otype>AuthorshipType</otype>
            <mtid>1</mtid>
            <link>/api/authorshiptype/1</link>
            <label>Author</label>
            <code>0</code>
            <published>true</published>
            <oldId>0</oldId>
            <snippet>true</snippet>
          </type>
          <published>false</published>
          <snippet>true</snippet>
        </authorship>
        <authorship>
          <otype>PersonAuthorship</otype>
          <mtid>109572213</mtid>
          <link>/api/authorship/109572213</link>
          <label>Zhang, W.</label>
          <listPosition>10</listPosition>
          <share>0.09090909</share>
          <first>false</first>
          <last>false</last>
          <corresponding>false</corresponding>
          <familyName>Zhang</familyName>
          <givenName>W.</givenName>
          <authorTyped>true</authorTyped>
          <editorTyped>false</editorTyped>
          <otherTyped>false</otherTyped>
          <type>
            <otype>AuthorshipType</otype>
            <mtid>1</mtid>
            <link>/api/authorshiptype/1</link>
            <label>Author</label>
            <code>0</code>
            <published>true</published>
            <oldId>0</oldId>
            <snippet>true</snippet>
          </type>
          <published>false</published>
          <snippet>true</snippet>
        </authorship>
        <authorship>
          <otype>PersonAuthorship</otype>
          <mtid>109572214</mtid>
          <link>/api/authorship/109572214</link>
          <label>Zhang, X. ✉</label>
          <listPosition>11</listPosition>
          <share>0.09090909</share>
          <first>false</first>
          <last>true</last>
          <corresponding>true</corresponding>
          <familyName>Zhang</familyName>
          <givenName>X.</givenName>
          <authorTyped>true</authorTyped>
          <editorTyped>false</editorTyped>
          <otherTyped>false</otherTyped>
          <type>
            <otype>AuthorshipType</otype>
            <mtid>1</mtid>
            <link>/api/authorshiptype/1</link>
            <label>Author</label>
            <code>0</code>
            <published>true</published>
            <oldId>0</oldId>
            <snippet>true</snippet>
          </type>
          <published>false</published>
          <snippet>true</snippet>
        </authorship>
      </authorships>
      <identifiers>
        <identifier>
          <otype>PublicationIdentifier</otype>
          <mtid>24249013</mtid>
          <link>/api/publicationidentifier/24249013</link>
          <label>DOI: 10.1016/j.canlet.2023.216307</label>
          <source>
            <otype>PlainSource</otype>
            <mtid>6</mtid>
            <link>/api/publicationsource/6</link>
            <label>DOI</label>
            <type>
              <otype>PublicationSourceType</otype>
              <mtid>10001</mtid>
              <link>/api/publicationsourcetype/10001</link>
              <label>DOI</label>
              <mayHaveOa>true</mayHaveOa>
              <published>true</published>
              <snippet>true</snippet>
            </type>
            <name>DOI</name>
            <nameEng>DOI</nameEng>
            <linkPattern>https://doi.org/@@@</linkPattern>
            <publiclyVisible>true</publiclyVisible>
            <published>true</published>
            <oldId>6</oldId>
            <snippet>true</snippet>
          </source>
          <oaType>PAY</oaType>
          <validState>IDENTICAL</validState>
          <idValue>10.1016/j.canlet.2023.216307</idValue>
          <realUrl>https://doi.org/10.1016/j.canlet.2023.216307</realUrl>
          <published>false</published>
          <snippet>true</snippet>
        </identifier>
        <identifier>
          <otype>PublicationIdentifier</otype>
          <mtid>24375915</mtid>
          <link>/api/publicationidentifier/24375915</link>
          <label>WoS: 001056616500001</label>
          <source>
            <otype>PlainSource</otype>
            <mtid>1</mtid>
            <link>/api/publicationsource/1</link>
            <label>WoS</label>
            <type>
              <otype>PublicationSourceType</otype>
              <mtid>10003</mtid>
              <link>/api/publicationsourcetype/10003</link>
              <label>Indexelő adatbázis</label>
              <mayHaveOa>false</mayHaveOa>
              <published>true</published>
              <snippet>true</snippet>
            </type>
            <name>WoS</name>
            <nameEng>WoS</nameEng>
            <linkPattern>https://www.webofscience.com/wos/woscc/full-record/@@@</linkPattern>
            <publiclyVisible>true</publiclyVisible>
            <published>true</published>
            <oldId>1</oldId>
            <snippet>true</snippet>
          </source>
          <validState>IDENTICAL</validState>
          <idValue>001056616500001</idValue>
          <realUrl>https://www.webofscience.com/wos/woscc/full-record/001056616500001</realUrl>
          <published>true</published>
          <snippet>true</snippet>
        </identifier>
        <identifier>
          <otype>PublicationIdentifier</otype>
          <mtid>24249012</mtid>
          <link>/api/publicationidentifier/24249012</link>
          <label>Scopus: 85166563267</label>
          <source>
            <otype>PlainSource</otype>
            <mtid>3</mtid>
            <link>/api/publicationsource/3</link>
            <label>Scopus</label>
            <type>
              <otype>PublicationSourceType</otype>
              <mtid>10003</mtid>
              <link>/api/publicationsourcetype/10003</link>
              <label>Indexelő adatbázis</label>
              <mayHaveOa>false</mayHaveOa>
              <published>true</published>
              <snippet>true</snippet>
            </type>
            <name>Scopus</name>
            <nameEng>Scopus</nameEng>
            <linkPattern>http://www.scopus.com/record/display.url?origin=inward&amp;eid=2-s2.0-@@@</linkPattern>
            <publiclyVisible>true</publiclyVisible>
            <published>true</published>
            <oldId>3</oldId>
            <snippet>true</snippet>
          </source>
          <validState>IDENTICAL</validState>
          <idValue>85166563267</idValue>
          <realUrl>http://www.scopus.com/record/display.url?origin=inward&amp;eid=2-s2.0-85166563267</realUrl>
          <published>false</published>
          <snippet>true</snippet>
        </identifier>
        <identifier>
          <otype>PublicationIdentifier</otype>
          <mtid>24375940</mtid>
          <link>/api/publicationidentifier/24375940</link>
          <label>PubMed: 37451426</label>
          <source>
            <otype>PlainSource</otype>
            <mtid>17</mtid>
            <link>/api/publicationsource/17</link>
            <label>PubMed</label>
            <type>
              <otype>PublicationSourceType</otype>
              <mtid>10003</mtid>
              <link>/api/publicationsourcetype/10003</link>
              <label>Indexelő adatbázis</label>
              <mayHaveOa>false</mayHaveOa>
              <published>true</published>
              <snippet>true</snippet>
            </type>
            <name>PubMed</name>
            <nameEng>PubMed</nameEng>
            <linkPattern>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=@@@&amp;dopt=Abstract</linkPattern>
            <publiclyVisible>true</publiclyVisible>
            <published>true</published>
            <oldId>17</oldId>
            <snippet>true</snippet>
          </source>
          <validState>IDENTICAL</validState>
          <idValue>37451426</idValue>
          <realUrl>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=37451426&amp;dopt=Abstract</realUrl>
          <published>false</published>
          <snippet>true</snippet>
        </identifier>
      </identifiers>
      <keywords>
        <keyword>
          <otype>Keyword</otype>
          <mtid>300</mtid>
          <link>/api/keyword/300</link>
          <label>APOPTOSIS</label>
          <published>true</published>
          <oldId>300</oldId>
          <snippet>true</snippet>
        </keyword>
        <keyword>
          <otype>Keyword</otype>
          <mtid>1009477</mtid>
          <link>/api/keyword/1009477</link>
          <label>Cell Death</label>
          <published>true</published>
          <oldId>1009477</oldId>
          <snippet>true</snippet>
        </keyword>
        <keyword>
          <otype>Keyword</otype>
          <mtid>1011214</mtid>
          <link>/api/keyword/1011214</link>
          <label>drug sensitivity</label>
          <published>true</published>
          <oldId>1011214</oldId>
          <snippet>true</snippet>
        </keyword>
        <keyword>
          <otype>Keyword</otype>
          <mtid>1027167</mtid>
          <link>/api/keyword/1027167</link>
          <label>Autophagy</label>
          <published>true</published>
          <oldId>1027167</oldId>
          <snippet>true</snippet>
        </keyword>
        <keyword>
          <otype>Keyword</otype>
          <mtid>1131609</mtid>
          <link>/api/keyword/1131609</link>
          <label>Chemoresistance</label>
          <published>true</published>
          <oldId>1131609</oldId>
          <snippet>true</snippet>
        </keyword>
        <keyword>
          <otype>Keyword</otype>
          <mtid>1745453</mtid>
          <link>/api/keyword/1745453</link>
          <label>Cancer drug resistance</label>
          <published>true</published>
          <snippet>true</snippet>
        </keyword>
      </keywords>
      <ratings>
        <rating>
          <otype>SjrRating</otype>
          <mtid>11403659</mtid>
          <link>/api/sjrrating/11403659</link>
          <label>sjr:D1 (2023) Scopus - Oncology CANCER LETTERS 0304-3835 1872-7980</label>
          <listPos>39</listPos>
          <rankValue>0.1</rankValue>
          <type>journal</type>
          <ratingType>
            <otype>RatingType</otype>
            <mtid>10002</mtid>
            <link>/api/ratingtype/10002</link>
            <label>sjr</label>
            <code>sjr</code>
            <published>true</published>
            <snippet>true</snippet>
          </ratingType>
          <subject>
            <otype>ClassificationExternal</otype>
            <mtid>2730</mtid>
            <link>/api/classificationexternal/2730</link>
            <label>Scopus - Oncology</label>
            <published>true</published>
            <oldId>2730</oldId>
            <snippet>true</snippet>
          </subject>
          <ranking>D1</ranking>
          <calculation>DIRECT</calculation>
          <published>true</published>
          <snippet>true</snippet>
        </rating>
      </ratings>
      <references>
        <reference>
          <otype>Reference</otype>
          <mtid>44270248</mtid>
          <link>/api/reference/44270248</link>
          <label>1. Shibue, T., Weinberg, R.A., EMT, CSCs, and drug resistance: the mechanistic link and clinical implications (2017) Nat. Rev. Clin. Oncol., 14 (10), pp. 611-629</label>
          <listPosition>1</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270249</mtid>
          <link>/api/reference/44270249</link>
          <label>2. Alizadeh, A.A., Toward understanding and exploiting tumor heterogeneity (2015) Nat. Med., 21 (8), pp. 846-853</label>
          <listPosition>2</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270250</mtid>
          <link>/api/reference/44270250</link>
          <label>3. Easwaran, H., Tsai, H.C., Baylin, S.B., Cancer epigenetics: tumor heterogeneity, plasticity of stem-like states, and drug resistance (2014) Mol. Cell., 54 (5), pp. 716-727</label>
          <listPosition>3</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270251</mtid>
          <link>/api/reference/44270251</link>
          <label>4. Burrell, R.A., The causes and consequences of genetic heterogeneity in cancer evolution (2013) Nature, 501 (7467), pp. 338-345</label>
          <listPosition>4</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270252</mtid>
          <link>/api/reference/44270252</link>
          <label>5. Vogelstein, B., Cancer genome landscapes (2013) Science, 339 (6127), pp. 1546-1558</label>
          <listPosition>5</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270253</mtid>
          <link>/api/reference/44270253</link>
          <label>6. Garraway, L.A., Lander, E.S., Lessons from the cancer genome (2013) Cell, 153 (1), pp. 17-37</label>
          <listPosition>6</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270254</mtid>
          <link>/api/reference/44270254</link>
          <label>7. Jin, P., Mitochondrial adaptation in cancer drug resistance: prevalence, mechanisms, and management (2022) J. Hematol. Oncol., 15 (1), pp. 1-42</label>
          <listPosition>7</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270255</mtid>
          <link>/api/reference/44270255</link>
          <label>8. Mirzaei, S., Caffeic acid and its derivatives as potential modulators of oncogenic molecular pathways: new hope in the fight against cancer (2021) Pharmacol. Res., 171</label>
          <listPosition>8</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270256</mtid>
          <link>/api/reference/44270256</link>
          <label>9. Gong, K., TNF-driven adaptive response mediates resistance to EGFR inhibition in lung cancer (2018) J. Clin. Invest., 128 (6), pp. 2500-2518</label>
          <listPosition>9</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270257</mtid>
          <link>/api/reference/44270257</link>
          <label>10. Eritja, N., Autophagy orchestrates adaptive responses to targeted therapy in endometrial cancer (2017) Autophagy, 13 (3), pp. 608-624</label>
          <listPosition>10</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270258</mtid>
          <link>/api/reference/44270258</link>
          <label>11. Ghosh, J.C., Adaptive mitochondrial reprogramming and resistance to PI3K therapy (2015) J. Natl. Cancer Inst., 107 (3)</label>
          <listPosition>11</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270259</mtid>
          <link>/api/reference/44270259</link>
          <label>12. Ashrafizaveh, S., Long non-coding RNAs in the doxorubicin resistance of cancer cells (2021) Cancer Lett., 508, pp. 104-114</label>
          <listPosition>12</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270260</mtid>
          <link>/api/reference/44270260</link>
          <label>13. Mirzaei, S., Nrf2 signaling pathway in cisplatin chemotherapy: potential involvement in organ protection and chemoresistance (2021) Pharmacol. Res., 167</label>
          <listPosition>13</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270261</mtid>
          <link>/api/reference/44270261</link>
          <label>14. Yang, L., Targeting cancer stem cell pathways for cancer therapy (2020) Signal Transduct. Targeted Ther., 5 (1), p. 8</label>
          <listPosition>14</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270262</mtid>
          <link>/api/reference/44270262</link>
          <label>15. Payandeh, Z., Role of Nrf2 and mitochondria in cancer stem cells</label>
          <listPosition>15</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270263</mtid>
          <link>/api/reference/44270263</link>
          <label>16. in carcinogenesis, tumor progression, and chemoresistance (2020) Biochimie, 179, pp. 32-45</label>
          <listPosition>16</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270264</mtid>
          <link>/api/reference/44270264</link>
          <label>17. Qin, S., Harnessing redox signaling to overcome therapeutic-resistant cancer dormancy (2022) Biochim. Biophys. Acta Rev. Canc, 1877 (4)</label>
          <listPosition>17</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270265</mtid>
          <link>/api/reference/44270265</link>
          <label>18. Li, B., Redox control of the dormant cancer cell life cycle (2021) Cells, 10 (10)</label>
          <listPosition>18</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270266</mtid>
          <link>/api/reference/44270266</link>
          <label>19. Ward, R.A., Challenges and opportunities in cancer drug resistance (2020) Chem. Rev., 121 (6), pp. 3297-3351</label>
          <listPosition>19</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270267</mtid>
          <link>/api/reference/44270267</link>
          <label>20. Green, D.R., Evan, G.I., A matter of life and death (2002) Cancer Cell, 1 (1), pp. 19-30</label>
          <listPosition>20</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270268</mtid>
          <link>/api/reference/44270268</link>
          <label>21. Pommier, Y., Apoptosis defects and chemotherapy resistance: molecular interaction maps and networks (2004) Oncogene, 23 (16), pp. 2934-2949</label>
          <listPosition>21</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270269</mtid>
          <link>/api/reference/44270269</link>
          <label>22. Carneiro, B.A., El-Deiry, W.S., Targeting apoptosis in cancer therapy (2020) Nat. Rev. Clin. Oncol., 17 (7), pp. 395-417</label>
          <listPosition>22</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270270</mtid>
          <link>/api/reference/44270270</link>
          <label>23. Zhivotovsky, B., Orrenius, S., Defects in the apoptotic machinery of cancer cells: role in drug resistance (2003) Seminars in Cancer Biology, , Elsevier</label>
          <listPosition>23</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270271</mtid>
          <link>/api/reference/44270271</link>
          <label>24. Indran, I.R., Recent advances in apoptosis, mitochondria and drug resistance in cancer cells (2011) Biochim. Biophys. Acta Bioenerg., 1807 (6), pp. 735-745</label>
          <listPosition>24</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270272</mtid>
          <link>/api/reference/44270272</link>
          <label>25. Zhu, T., Oncogenic circTICRR suppresses autophagy via binding to HuR protein and stabilizing GLUD1 mRNA in cervical cancer (2022) Cell Death Dis., 13 (5), p. 479</label>
          <listPosition>25</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270273</mtid>
          <link>/api/reference/44270273</link>
          <label>26. Yang, H.L., Antrodia salmonea induces apoptosis and enhances cytoprotective autophagy in colon cancer cells (2021) Aging (Albany NY), 13 (12), pp. 15964-15989</label>
          <listPosition>26</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270274</mtid>
          <link>/api/reference/44270274</link>
          <label>27. Liu, Y., TRPML1-induced autophagy inhibition triggers mitochondrial mediated apoptosis (2022) Cancer Lett., 541</label>
          <listPosition>27</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270275</mtid>
          <link>/api/reference/44270275</link>
          <label>28. Chen, H.T., Crosstalk between autophagy and epithelial-mesenchymal transition and its application in cancer therapy (2019) Mol. Cancer, 18 (1), p. 101</label>
          <listPosition>28</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270276</mtid>
          <link>/api/reference/44270276</link>
          <label>29. Marsh, T., Debnath, J., Autophagy suppresses breast cancer metastasis by degrading NBR1 (2020) Autophagy, 16 (6), pp. 1164-1165</label>
          <listPosition>29</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270277</mtid>
          <link>/api/reference/44270277</link>
          <label>30. Xing, Y., Autophagy inhibition mediated by MCOLN1/TRPML1 suppresses cancer metastasis via regulating a ROS-driven TP53/p53 pathway (2022) Autophagy, 18 (8), pp. 1932-1954</label>
          <listPosition>30</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270278</mtid>
          <link>/api/reference/44270278</link>
          <label>31. Klionsky, D.J., Autophagy in major human diseases (2021) EMBO J., 40 (19)</label>
          <listPosition>31</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270279</mtid>
          <link>/api/reference/44270279</link>
          <label>32. Gao, W., Autophagy, ferroptosis, pyroptosis, and necroptosis in tumor immunotherapy (2022) Signal Transduct. Targeted Ther., 7 (1), p. 196</label>
          <listPosition>32</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270280</mtid>
          <link>/api/reference/44270280</link>
          <label>33. Ashrafizadeh, M., Targeting autophagy in prostate cancer: preclinical and clinical evidence for therapeutic response (2022) J. Exp. Clin. Cancer Res., 41 (1), p. 105</label>
          <listPosition>33</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270281</mtid>
          <link>/api/reference/44270281</link>
          <label>34. Chadet, S., P2x4 receptor promotes mammary cancer progression by sustaining autophagy and associated mesenchymal transition (2022) Oncogene, 41 (21), pp. 2920-2931</label>
          <listPosition>34</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270282</mtid>
          <link>/api/reference/44270282</link>
          <label>35. Fan, H., ROS generation attenuates the anti-cancer effect of CPX on cervical cancer cells by inducing autophagy and inhibiting glycophagy (2022) Redox Biol., 53</label>
          <listPosition>35</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270283</mtid>
          <link>/api/reference/44270283</link>
          <label>36. Kao, C.H., TFEB- and TFE3-dependent autophagy activation supports cancer proliferation in the absence of centrosomes (2022) Autophagy, 18 (12), pp. 2830-2850</label>
          <listPosition>36</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270284</mtid>
          <link>/api/reference/44270284</link>
          <label>37. Bai, J., Autophagy loss impedes cancer-associated fibroblast activation via downregulating proline biosynthesis (2023) Autophagy, 19 (2), pp. 632-643</label>
          <listPosition>37</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270285</mtid>
          <link>/api/reference/44270285</link>
          <label>38. Khayati, K., Transient systemic autophagy inhibition is selectively and irreversibly deleterious to lung cancer (2022) Cancer Res., 82 (23), pp. 4429-4443</label>
          <listPosition>38</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270286</mtid>
          <link>/api/reference/44270286</link>
          <label>39. Yang, Y., TRIM27 cooperates with STK38L to inhibit ULK1-mediated autophagy and promote tumorigenesis (2022) EMBO J., 41 (14)</label>
          <listPosition>39</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270287</mtid>
          <link>/api/reference/44270287</link>
          <label>40. Li, Z., Engineering dual catalytic nanomedicine for autophagy-augmented and ferroptosis-involved cancer nanotherapy (2022) Biomaterials, 287</label>
          <listPosition>40</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270288</mtid>
          <link>/api/reference/44270288</link>
          <label>41. Huang, P., SIRT3-mediated autophagy contributes to ferroptosis-induced anticancer by inducing the formation of BECN1-SLC7A11 complex (2023) Biochem. Pharmacol., 213</label>
          <listPosition>41</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270289</mtid>
          <link>/api/reference/44270289</link>
          <label>42. Yang, Z., SIRT6 drives sensitivity to ferroptosis in anaplastic thyroid cancer through NCOA4-dependent autophagy (2023) Am J Cancer Res, 13 (2), pp. 464-474</label>
          <listPosition>42</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270290</mtid>
          <link>/api/reference/44270290</link>
          <label>43. Peng, X., Overexpression of LINC00551 promotes autophagy-dependent ferroptosis of lung adenocarcinoma via upregulating DDIT4 by sponging miR-4328 (2022) PeerJ, 10</label>
          <listPosition>43</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270291</mtid>
          <link>/api/reference/44270291</link>
          <label>44. Banik, I., P38 mediates tumor suppression through reduced autophagy and actin cytoskeleton changes in NRAS-mutant melanoma (2023) Cancers, 15 (3)</label>
          <listPosition>44</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270292</mtid>
          <link>/api/reference/44270292</link>
          <label>45. Yu, Z., Chloroquine inhibition of autophagy enhanced the anticancer effects of Listeria monocytogenes in melanoma (2023) Microorganisms, 11 (2)</label>
          <listPosition>45</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270293</mtid>
          <link>/api/reference/44270293</link>
          <label>46. Jeong, S., Lactobacillus plantarum metabolites elicit anticancer effects by inhibiting autophagy-related responses (2023) Molecules, 28 (4)</label>
          <listPosition>46</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270294</mtid>
          <link>/api/reference/44270294</link>
          <label>47. Wang, Y.X., Icaritin derivative IC2 induces cytoprotective autophagy of breast cancer cells via SCD1 inhibition (2023) Molecules, 28 (3)</label>
          <listPosition>47</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270295</mtid>
          <link>/api/reference/44270295</link>
          <label>48. Wan, X., Ciclopirox olamine induces proliferation inhibition and protective autophagy in hepatocellular carcinoma (2023) Pharmaceuticals, 16 (1)</label>
          <listPosition>48</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270296</mtid>
          <link>/api/reference/44270296</link>
          <label>49. Tang, Z.N., RANKL promotes chemotherapy resistance in breast cancer cells through STAT3 mediated autophagy induction (2023) Clin. Breast Cancer, 23 (4), pp. 388-396</label>
          <listPosition>49</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270297</mtid>
          <link>/api/reference/44270297</link>
          <label>50. Xie, Y., An ATG4B inhibitor blocks autophagy and sensitizes Sorafenib inhibition activities in HCC tumor cells (2023) Bioorg. Med. Chem., 84</label>
          <listPosition>50</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270298</mtid>
          <link>/api/reference/44270298</link>
          <label>51. Dai, X., KLF5-mediated aquaporin 3 activated autophagy to facilitate cisplatin resistance of gastric cancer (2023) Immunopharmacol. Immunotoxicol., 45 (2), pp. 140-152</label>
          <listPosition>51</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270299</mtid>
          <link>/api/reference/44270299</link>
          <label>52. Sun, Q., Engineering mitochondrial uncoupler synergistic photodynamic nanoplatform to harness immunostimulatory pro-death autophagy/mitophagy (2022) Biomaterials, 289</label>
          <listPosition>52</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270300</mtid>
          <link>/api/reference/44270300</link>
          <label>53. Bissell, M.J., Hall, H.G., Parry, G., How does the extracellular matrix direct gene expression? (1982) J. Theor. Biol., 99 (1), pp. 31-68</label>
          <listPosition>53</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270301</mtid>
          <link>/api/reference/44270301</link>
          <label>54. Chambers, A.F., Groom, A.C., MacDonald, I.C., Dissemination and growth of cancer cells in metastatic sites (2002) Nat. Rev. Cancer, 2 (8), pp. 563-572</label>
          <listPosition>54</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270302</mtid>
          <link>/api/reference/44270302</link>
          <label>55. Anlaş, A.A., Nelson, C.M., Soft microenvironments induce chemoresistance by increasing autophagy downstream of integrin-linked kinase (2020) Cancer Res., 80 (19), pp. 4103-4113</label>
          <listPosition>55</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270303</mtid>
          <link>/api/reference/44270303</link>
          <label>56. Gan, L., Mesenchymal stem cells promote chemoresistance by activating autophagy in intrahepatic cholangiocarcinoma (2021) Oncol. Rep., 45 (1), pp. 107-118</label>
          <listPosition>56</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270304</mtid>
          <link>/api/reference/44270304</link>
          <label>57. Xiu, T., CD13 downregulation mediated by ubenimex inhibits autophagy to overcome 5-FU resistance by disturbing the EMP3/FAK/NF-κB pathway in gastric cancer cells (2022) Transl. Cancer Res., 11 (8), pp. 2487-2500</label>
          <listPosition>57</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270305</mtid>
          <link>/api/reference/44270305</link>
          <label>58. Zhao, Y., CD13 induces autophagy to promote hepatocellular carcinoma cell chemoresistance through the P38/Hsp27/CREB/ATG7 pathway (2020) J. Pharmacol. Exp. Therapeut., 374 (3), pp. 512-520</label>
          <listPosition>58</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270306</mtid>
          <link>/api/reference/44270306</link>
          <label>59. Long, F., HIF-1α-induced autophagy contributes to cisplatin resistance in ovarian cancer cells (2018) Pharmazie, 73 (9), pp. 533-536</label>
          <listPosition>59</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270307</mtid>
          <link>/api/reference/44270307</link>
          <label>60. Wang, Q.X., Downregulation of CD44v6 enhances chemosensitivity by promoting apoptosis and inhibiting autophagy in colorectal cancer HT29 cells (2019) Ann. Clin. Lab. Sci., 49 (4), pp. 481-487</label>
          <listPosition>60</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270308</mtid>
          <link>/api/reference/44270308</link>
          <label>61. Yin, L., Crystal structure of human SH3BGRL protein: the first structure of the human SH3BGR family representing a novel class of thioredoxin fold proteins (2005) Proteins, 61 (1), pp. 213-216</label>
          <listPosition>61</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270309</mtid>
          <link>/api/reference/44270309</link>
          <label>62. Cesareni, G., Can we infer peptide recognition specificity mediated by SH3 domains? (2002) FEBS Lett., 513 (1), pp. 38-44</label>
          <listPosition>62</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270310</mtid>
          <link>/api/reference/44270310</link>
          <label>63. Zhang, S., Adaptor SH3BGRL drives autophagy-mediated chemoresistance through promoting PIK3C3 translation and ATG12 stability in breast cancers (2022) Autophagy, 18 (8), pp. 1822-1840</label>
          <listPosition>63</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270311</mtid>
          <link>/api/reference/44270311</link>
          <label>64. Loh, J.S., Simultaneous proteasome and autophagy inhibition synergistically enhances cytotoxicity of doxorubicin in breast cancer cells (2022) Cell Biochem. Funct., 40 (4), pp. 403-416</label>
          <listPosition>64</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270312</mtid>
          <link>/api/reference/44270312</link>
          <label>65. Sachdeva, R., ID1 is critical for tumorigenesis and regulates chemoresistance in glioblastoma (2019) Cancer Res., 79 (16), pp. 4057-4071</label>
          <listPosition>65</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270313</mtid>
          <link>/api/reference/44270313</link>
          <label>66. Yin, X., ID1 promotes hepatocellular carcinoma proliferation and confers chemoresistance to oxaliplatin by activating pentose phosphate pathway (2017) J. Exp. Clin. Cancer Res., 36 (1), p. 166</label>
          <listPosition>66</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270314</mtid>
          <link>/api/reference/44270314</link>
          <label>67. Han, L., MicroRNA-338-5p reverses chemoresistance and inhibits invasion of esophageal squamous cell carcinoma cells by targeting Id-1 (2019) Cancer Sci., 110 (12), pp. 3677-3688</label>
          <listPosition>67</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270315</mtid>
          <link>/api/reference/44270315</link>
          <label>68. Meng, J., ID1 confers cancer cell chemoresistance through STAT3/ATF6-mediated induction of autophagy (2020) Cell Death Dis., 11 (2), p. 137</label>
          <listPosition>68</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270316</mtid>
          <link>/api/reference/44270316</link>
          <label>69. Xu, W., Rab5a suppresses autophagy to promote drug resistance in cancer cells (2018) Am J Transl Res, 10 (4), pp. 1229-1236</label>
          <listPosition>69</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270317</mtid>
          <link>/api/reference/44270317</link>
          <label>70. Yang, K., M2 tumor-associated macrophage mediates the maintenance of stemness to promote cisplatin resistance by secreting TGF-β1 in esophageal squamous cell carcinoma (2023) J. Transl. Med., 21 (1), p. 26</label>
          <listPosition>70</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270318</mtid>
          <link>/api/reference/44270318</link>
          <label>71. Yin, W., Inhibition of autophagy promotes the elimination of liver cancer stem cells by CD133 aptamer-targeted delivery of doxorubicin (2022) Biomolecules, 12 (11)</label>
          <listPosition>71</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270319</mtid>
          <link>/api/reference/44270319</link>
          <label>72. Xie, R., Furin-instructed aggregated gold nanoparticles for re-educating tumor associated macrophages and overcoming breast cancer chemoresistance (2021) Biomaterials, 275</label>
          <listPosition>72</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270320</mtid>
          <link>/api/reference/44270320</link>
          <label>73. Yu, J., SOCS5 contributes to temozolomide resistance in glioblastoma by regulating Bcl-2-mediated autophagy (2022) Bioengineered, 13 (6), pp. 14125-14137</label>
          <listPosition>73</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270321</mtid>
          <link>/api/reference/44270321</link>
          <label>74. Huang, J., MALAT1 modulates the autophagy of retinoblastoma cell through miR-124-mediated stx17 regulation (2018) J. Cell. Biochem., 119 (5), pp. 3853-3863</label>
          <listPosition>74</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270322</mtid>
          <link>/api/reference/44270322</link>
          <label>75. Zhou, F., Down-regulation of OGT promotes cisplatin resistance by inducing autophagy in ovarian cancer (2018) Theranostics, 8 (19), pp. 5200-5212</label>
          <listPosition>75</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270323</mtid>
          <link>/api/reference/44270323</link>
          <label>76. Liu, B., Med19 is involved in chemoresistance by mediating autophagy through HMGB1 in breast cancer (2019) J. Cell. Biochem., 120 (1), pp. 507-518</label>
          <listPosition>76</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270324</mtid>
          <link>/api/reference/44270324</link>
          <label>77. Zhu, W., FGF19 promotes cell autophagy and cisplatin chemoresistance by activating MAPK signaling in ovarian cancer (2023) PeerJ, 11</label>
          <listPosition>77</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270325</mtid>
          <link>/api/reference/44270325</link>
          <label>78. Luo, W., FXYD6 regulates chemosensitivity by mediating the expression of Na+/K+-ATPase α1 and affecting cell autophagy and apoptosis in colorectal cancer (2021) BioMed Res. Int., 2021</label>
          <listPosition>78</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270326</mtid>
          <link>/api/reference/44270326</link>
          <label>79. Mirzaei, S., Pre-clinical and clinical applications of small interfering RNAs (siRNA) and co-delivery systems for pancreatic cancer therapy (2021) Cells, 10 (12), p. 3348</label>
          <listPosition>79</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270327</mtid>
          <link>/api/reference/44270327</link>
          <label>80. Li, W., MiTF is associated with chemoresistance to cisplatin in A549 lung cancer cells via modulating lysosomal biogenesis and autophagy (2020) Cancer Manag. Res., 12, pp. 6563-6573</label>
          <listPosition>80</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270328</mtid>
          <link>/api/reference/44270328</link>
          <label>81. Xu, W., CCL2-SQSTM1 positive feedback loop suppresses autophagy to promote chemoresistance in gastric cancer (2018) Int. J. Biol. Sci., 14 (9), pp. 1054-1066</label>
          <listPosition>81</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270329</mtid>
          <link>/api/reference/44270329</link>
          <label>82. Liu, D.X., Exosomes derived from HBV-associated liver cancer promote chemoresistance by upregulating chaperone-mediated autophagy (2019) Oncol. Lett., 17 (1), pp. 323-331</label>
          <listPosition>82</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270330</mtid>
          <link>/api/reference/44270330</link>
          <label>83. Shen, W., NRBF2 regulates the chemoresistance of small cell lung cancer by interacting with the P62 protein in the autophagy process (2022) iScience, 25 (6)</label>
          <listPosition>83</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270331</mtid>
          <link>/api/reference/44270331</link>
          <label>84. Pei, L., Heme oxygenase-1 induction mediates chemoresistance of breast cancer cells to pharmorubicin by promoting autophagy via PI3K/Akt pathway (2018) J. Cell Mol. Med., 22 (11), pp. 5311-5321</label>
          <listPosition>84</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270332</mtid>
          <link>/api/reference/44270332</link>
          <label>85. Ma, K., Exploring the mechanism of cisplatin resistance by transcriptome sequencing and reversing the chemoresistance by autophagy inhibition in small cell lung cancer (2020) Biochem. Biophys. Res. Commun., 533 (3), pp. 474-480</label>
          <listPosition>85</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270333</mtid>
          <link>/api/reference/44270333</link>
          <label>86. Zhao, Y., WWOX promotes apoptosis and inhibits autophagy in paclitaxel-treated ovarian carcinoma cells (2021) Mol. Med. Rep., 23 (2)</label>
          <listPosition>86</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270334</mtid>
          <link>/api/reference/44270334</link>
          <label>87. Han, Q., Solamargine induces autophagy-mediated apoptosis and enhances bortezomib activity in multiple myeloma (2022) Clin. Exp. Pharmacol. Physiol., 49 (6), pp. 674-685</label>
          <listPosition>87</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270335</mtid>
          <link>/api/reference/44270335</link>
          <label>88. Fan, L.X., Cx32 promotes autophagy and produces resistance to SN-induced apoptosis via activation of AMPK signalling in cervical cancer (2022) Int. J. Oncol., 60 (1)</label>
          <listPosition>88</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270336</mtid>
          <link>/api/reference/44270336</link>
          <label>89. Feng, X., MiR-25 enhances autophagy and promotes sorafenib resistance of hepatocellular carcinoma via targeting FBXW7 (2022) Int. J. Med. Sci., 19 (2), pp. 257-266</label>
          <listPosition>89</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270337</mtid>
          <link>/api/reference/44270337</link>
          <label>90. Li, D., Cholesterol sensor SCAP contributes to sorafenib resistance by regulating autophagy in hepatocellular carcinoma (2022) J. Exp. Clin. Cancer Res., 41 (1), p. 116</label>
          <listPosition>90</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270338</mtid>
          <link>/api/reference/44270338</link>
          <label>91. Benegiamo, G., The RNA-binding protein NONO coordinates hepatic adaptation to feeding (2018) Cell Metabol., 27 (2), pp. 404-418s. , e7</label>
          <listPosition>91</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270339</mtid>
          <link>/api/reference/44270339</link>
          <label>92. Sinha, R.A., Nonalcoholic fatty liver disease and hypercholesterolemia: roles of thyroid Hormones, metabolites, and agonists (2019) Thyroid, 29 (9), pp. 1173-1191</label>
          <listPosition>92</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270340</mtid>
          <link>/api/reference/44270340</link>
          <label>93. Lee, S.H., Lee, J.H., Im, S.S., The cellular function of SCAP in metabolic signaling (2020) Exp. Mol. Med., 52 (5), pp. 724-729</label>
          <listPosition>93</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270341</mtid>
          <link>/api/reference/44270341</link>
          <label>94. Sakai, J., Rawson, R.B., The sterol regulatory element-binding protein pathway: control of lipid homeostasis through regulated intracellular transport (2001) Curr. Opin. Lipidol., 12 (3), pp. 261-266</label>
          <listPosition>94</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270342</mtid>
          <link>/api/reference/44270342</link>
          <label>95. Wang, C., Combination of polythyleneimine regulating autophagy prodrug and Mdr1 siRNA for tumor multidrug resistance (2022) J. Nanobiotechnol., 20 (1), p. 476</label>
          <listPosition>95</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270343</mtid>
          <link>/api/reference/44270343</link>
          <label>96. Sun, W.L., Autophagy facilitates multidrug resistance development through inhibition of apoptosis in breast cancer cells (2015) Neoplasma, 62 (2), pp. 199-208</label>
          <listPosition>96</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270344</mtid>
          <link>/api/reference/44270344</link>
          <label>97. Chen, Z., NPRL2 enhances autophagy and the resistance to Everolimus in castration-resistant prostate cancer (2019) Prostate, 79 (1), pp. 44-53</label>
          <listPosition>97</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270345</mtid>
          <link>/api/reference/44270345</link>
          <label>98. Xiao, F., Trim14 promotes autophagy and chemotherapy resistance of gastric cancer cells by regulating AMPK/mTOR pathway (2020) Drug Dev. Res., 81 (5), pp. 544-550</label>
          <listPosition>98</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270346</mtid>
          <link>/api/reference/44270346</link>
          <label>99. Jang, J.E., PERK/NRF2 and autophagy form a resistance mechanism against G9a inhibition in leukemia stem cells (2020) J. Exp. Clin. Cancer Res., 39 (1), p. 66</label>
          <listPosition>99</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270347</mtid>
          <link>/api/reference/44270347</link>
          <label>100. Futerman, A.H., Hannun, Y.A., The complex life of simple sphingolipids (2004) EMBO Rep., 5 (8), pp. 777-782</label>
          <listPosition>100</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270348</mtid>
          <link>/api/reference/44270348</link>
          <label>101. Ogretmen, B., Hannun, Y.A., Biologically active sphingolipids in cancer pathogenesis and treatment (2004) Nat. Rev. Cancer, 4 (8), pp. 604-616</label>
          <listPosition>101</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270349</mtid>
          <link>/api/reference/44270349</link>
          <label>102. Hannun, Y.A., Obeid, L.M., Principles of bioactive lipid signalling: lessons from sphingolipids (2008) Nat. Rev. Mol. Cell Biol., 9 (2), pp. 139-150</label>
          <listPosition>102</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270350</mtid>
          <link>/api/reference/44270350</link>
          <label>103. Realini, N., Acid ceramidase in melanoma: expression, localization, and effects of pharmacological inhibition (2016) J. Biol. Chem., 291 (5), pp. 2422-2434</label>
          <listPosition>103</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270351</mtid>
          <link>/api/reference/44270351</link>
          <label>104. Lai, M., Complete Acid Ceramidase ablation prevents cancer-initiating cell formation in melanoma cells (2017) Sci. Rep., 7 (1), p. 7411</label>
          <listPosition>104</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270352</mtid>
          <link>/api/reference/44270352</link>
          <label>105. Lai, M., Sphingolipid/Ceramide pathways and autophagy in the onset and progression of melanoma: novel therapeutic targets and opportunities (2019) Int. J. Mol. Sci., 20 (14)</label>
          <listPosition>105</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270353</mtid>
          <link>/api/reference/44270353</link>
          <label>106. Aflaki, E., C16 ceramide is crucial for triacylglycerol-induced apoptosis in macrophages (2012) Cell Death Dis., 3 (3), p. e280</label>
          <listPosition>106</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270354</mtid>
          <link>/api/reference/44270354</link>
          <label>107. Siskind, L.J., Colombini, M., The lipids C2- and C16-ceramide form large stable channels. Implications for apoptosis (2000) J. Biol. Chem., 275 (49), pp. 38640-38644</label>
          <listPosition>107</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270355</mtid>
          <link>/api/reference/44270355</link>
          <label>108. Lai, M., Acid ceramidase controls apoptosis and increases autophagy in human melanoma cells treated with doxorubicin (2021) Sci. Rep., 11 (1)</label>
          <listPosition>108</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270356</mtid>
          <link>/api/reference/44270356</link>
          <label>109. Chen, J., The loss of SHMT2 mediates 5-fluorouracil chemoresistance in colorectal cancer by upregulating autophagy (2021) Oncogene, 40 (23), pp. 3974-3988</label>
          <listPosition>109</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270357</mtid>
          <link>/api/reference/44270357</link>
          <label>110. Wang, Y., Overexpression of ARHI increases the sensitivity of cervical cancer cells to paclitaxel through inducing apoptosis and autophagy (2022) Drug Dev. Res., 83 (1), pp. 142-149</label>
          <listPosition>110</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270358</mtid>
          <link>/api/reference/44270358</link>
          <label>111. Sun, W.L., Autophagy protects breast cancer cells from epirubicin-induced apoptosis and facilitates epirubicin-resistance development (2011) Autophagy, 7 (9), pp. 1035-1044</label>
          <listPosition>111</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270359</mtid>
          <link>/api/reference/44270359</link>
          <label>112. Dixon, S.J., Ferroptosis: an iron-dependent form of nonapoptotic cell death (2012) Cell, 149 (5), pp. 1060-1072</label>
          <listPosition>112</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270360</mtid>
          <link>/api/reference/44270360</link>
          <label>113. Li, Y., Down-regulation of PSMD4 can attenuate autophagy, enhance the accumulation of intracellular ROS, and increase the sensitivity of epithelial ovarian cancer to carboplatin by inhibiting the NF-κB pathway (2021) Transl. Cancer Res., 10 (11), pp. 4756-4772</label>
          <listPosition>113</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270361</mtid>
          <link>/api/reference/44270361</link>
          <label>114. Li, B., CISD2 promotes resistance to sorafenib-induced ferroptosis by regulating autophagy in hepatocellular carcinoma (2021) Front. Oncol., 11</label>
          <listPosition>114</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270362</mtid>
          <link>/api/reference/44270362</link>
          <label>115. Das, C.K., BAG3 overexpression and cytoprotective autophagy mediate apoptosis resistance in chemoresistant breast cancer cells (2018) Neoplasia, 20 (3), pp. 263-279</label>
          <listPosition>115</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270363</mtid>
          <link>/api/reference/44270363</link>
          <label>116. Zhao, Z., Autophagy inhibition promotes bevacizumab-induced apoptosis and proliferation inhibition in colorectal cancer cells (2018) J. Cancer, 9 (18), pp. 3407-3416</label>
          <listPosition>116</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270364</mtid>
          <link>/api/reference/44270364</link>
          <label>117. Bai, Z., Esomeprazole overcomes paclitaxel-resistance and enhances anticancer effects of paclitaxel by inducing autophagy in A549/Taxol cells (2021) Cell Biol. Int., 45 (1), pp. 177-187</label>
          <listPosition>117</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270365</mtid>
          <link>/api/reference/44270365</link>
          <label>118. Chen, S., A Bim-targeting strategy overcomes adaptive bortezomib resistance in myeloma through a novel link between autophagy and apoptosis (2014) Blood, 124 (17), pp. 2687-2697</label>
          <listPosition>118</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270366</mtid>
          <link>/api/reference/44270366</link>
          <label>119. Lei, T., HMGB1-mediated autophagy promotes gefitinib resistance in human non-small cell lung cancer (2022) Acta Biochim. Biophys. Sin., 54 (4). , (fpage-lpage)</label>
          <listPosition>119</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270367</mtid>
          <link>/api/reference/44270367</link>
          <label>120. Huang, Y., KIF23 promotes autophagy-induced imatinib resistance in chronic myeloid leukaemia through activating Wnt/β-catenin pathway (2022) Clin. Exp. Pharmacol. Physiol., 49 (12), pp. 1334-1341</label>
          <listPosition>120</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270368</mtid>
          <link>/api/reference/44270368</link>
          <label>121. Wang, J., Xanthine oxidoreductase mediates genotoxic drug-induced autophagy and apoptosis resistance by uric acid accumulation and TGF-β-activated kinase 1 (TAK1) activation (2023) Faseb. J., 37 (2)</label>
          <listPosition>121</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270369</mtid>
          <link>/api/reference/44270369</link>
          <label>122. Lu, C., Protective autophagy decreases lorlatinib cytotoxicity through Foxo3a-dependent inhibition of apoptosis in NSCLC (2022) Cell Death Dis., 8 (1), p. 221</label>
          <listPosition>122</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270370</mtid>
          <link>/api/reference/44270370</link>
          <label>123. Xin, M., Autophagy inhibition enhances the anti-tumor activity of methylseleninic acid in cisplatin-resistance human lung adenocarcinoma cells (2022) Front. Pharmacol., 13</label>
          <listPosition>123</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270371</mtid>
          <link>/api/reference/44270371</link>
          <label>124. Li, H., miR-519a enhances chemosensitivity and promotes autophagy in glioblastoma by targeting STAT3/Bcl2 signaling pathway (2018) J. Hematol. Oncol., 11 (1), p. 70</label>
          <listPosition>124</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270372</mtid>
          <link>/api/reference/44270372</link>
          <label>125. Hong, X., CircIPO7 promotes nasopharyngeal carcinoma metastasis and cisplatin chemoresistance by facilitating YBX1 nuclear localization (2022) Clin. Cancer Res., 28 (20), pp. 4521-4535</label>
          <listPosition>125</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270373</mtid>
          <link>/api/reference/44270373</link>
          <label>126. Shi, Q., Increased glucose metabolism in TAMs fuels O-GlcNAcylation of lysosomal Cathepsin B to promote cancer metastasis and chemoresistance (2022) Cancer Cell, 40 (10), pp. 1207-1222. , e10</label>
          <listPosition>126</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270374</mtid>
          <link>/api/reference/44270374</link>
          <label>127. Lin, F., Stanniocalcin 1 promotes metastasis, lipid metabolism and cisplatin chemoresistance via the FOXC2/ITGB6 signaling axis in ovarian cancer (2022) J. Exp. Clin. Cancer Res., 41 (1), p. 129</label>
          <listPosition>127</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270375</mtid>
          <link>/api/reference/44270375</link>
          <label>128. Datta, S., Autophagy inhibition with chloroquine reverts paclitaxel resistance and attenuates metastatic potential in human nonsmall lung adenocarcinoma A549 cells via ROS mediated modulation of β-catenin pathway (2019) Apoptosis, 24 (5-6), pp. 414-433</label>
          <listPosition>128</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270376</mtid>
          <link>/api/reference/44270376</link>
          <label>129. Ferraresi, A., Resveratrol contrasts LPA-induced ovarian cancer cell migration and platinum resistance by rescuing Hedgehog-mediated autophagy (2021) Cells, 10 (11)</label>
          <listPosition>129</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270377</mtid>
          <link>/api/reference/44270377</link>
          <label>130. Wang, H., Superenhancers activate the autophagy-related genes Beclin1 and LC3B to drive metastasis and drug resistance in osteosarcoma (2022) Front. Med., 16 (6), pp. 883-895</label>
          <listPosition>130</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270378</mtid>
          <link>/api/reference/44270378</link>
          <label>131. Kaushik, S., Cuervo, A.M., Chaperone-mediated autophagy: a unique way to enter the lysosome world (2012) Trends Cell Biol., 22 (8), pp. 407-417</label>
          <listPosition>131</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270379</mtid>
          <link>/api/reference/44270379</link>
          <label>132. Catarino, S., Pereira, P., Girão, H., Molecular control of chaperone-mediated autophagy (2017) Essays Biochem., 61 (6), pp. 663-674</label>
          <listPosition>132</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270380</mtid>
          <link>/api/reference/44270380</link>
          <label>133. Kaushik, S., Cuervo, A.M., The coming of age of chaperone-mediated autophagy (2018) Nat. Rev. Mol. Cell Biol., 19 (6), pp. 365-381</label>
          <listPosition>133</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270381</mtid>
          <link>/api/reference/44270381</link>
          <label>134. Xuan, Y., Inhibition of chaperone-mediated autophagy reduces tumor growth and metastasis and promotes drug sensitivity in colorectal cancer (2021) Mol. Med. Rep., 23 (5)</label>
          <listPosition>134</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270382</mtid>
          <link>/api/reference/44270382</link>
          <label>135. Ma, H., PBK, targeted by EVI1, promotes metastasis and confers cisplatin resistance through inducing autophagy in high-grade serous ovarian carcinoma (2019) Cell Death Dis., 10 (3), p. 166</label>
          <listPosition>135</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270383</mtid>
          <link>/api/reference/44270383</link>
          <label>136. Han, B., Propofol decreases cisplatin resistance of non-small cell lung cancer by inducing GPX4-mediated ferroptosis through the miR-744-5p/miR-615-3p axis (2023) J. Proteonomics, 274</label>
          <listPosition>136</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270384</mtid>
          <link>/api/reference/44270384</link>
          <label>137. Zhang, Y.F., Propofol facilitates cisplatin sensitivity via lncRNA MALAT1/miR-30e/ATG5 axis through suppressing autophagy in gastric cancer (2020) Life Sci., 244</label>
          <listPosition>137</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270385</mtid>
          <link>/api/reference/44270385</link>
          <label>138. Okuno, K., Berberine overcomes gemcitabine-associated chemoresistance through regulation of Rap1/PI3K-akt signaling in pancreatic ductal adenocarcinoma (2022) Pharmaceuticals, 15 (10)</label>
          <listPosition>138</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270386</mtid>
          <link>/api/reference/44270386</link>
          <label>139. Qu, H., Berberine reduces temozolomide resistance by inducing autophagy via the ERK1/2 signaling pathway in glioblastoma (2020) Cancer Cell Int., 20 (1), p. 592</label>
          <listPosition>139</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270387</mtid>
          <link>/api/reference/44270387</link>
          <label>140. Wang, Y., Berberine reverses doxorubicin resistance by inhibiting autophagy through the PTEN/Akt/mTOR signaling pathway in breast cancer (2020) OncoTargets Ther., 13, pp. 1909-1919</label>
          <listPosition>140</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270388</mtid>
          <link>/api/reference/44270388</link>
          <label>141. Yang, H., Bisdemethoxycurcumin exerts pro-apoptotic effects in human pancreatic adenocarcinoma cells through mitochondrial dysfunction and a GRP78-dependent pathway (2016) Oncotarget, 7 (50), pp. 83641-83656</label>
          <listPosition>141</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270389</mtid>
          <link>/api/reference/44270389</link>
          <label>142. Wang, H.J., Bisdemethoxycurcumin sensitizes cisplatin-resistant lung cancer cells to chemotherapy by inhibition of CA916798 and PI3K/AKT signaling (2017) Apoptosis, 22 (9), pp. 1157-1168</label>
          <listPosition>142</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270390</mtid>
          <link>/api/reference/44270390</link>
          <label>143. Liao, C.L., Bisdemethoxycurcumin suppresses migration and invasion of human cervical cancer HeLa cells via inhibition of NF-ĸB, MMP-2 and -9 pathways (2018) Anticancer Res., 38 (7), pp. 3989-3997</label>
          <listPosition>143</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270391</mtid>
          <link>/api/reference/44270391</link>
          <label>144. Klingseisen, V., Bisdemethoxycurcumin sensitizes the response of cisplatin resistant non-small cell lung carcinoma cell lines by activating apoptosis and autophagy (2022) J. Nutr. Biochem., 106</label>
          <listPosition>144</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270392</mtid>
          <link>/api/reference/44270392</link>
          <label>145. Zhao, Y., Wang, C., Goel, A., A combined treatment with melatonin and andrographis promotes autophagy and anticancer activity in colorectal cancer (2022) Carcinogenesis, 43 (3), pp. 217-230</label>
          <listPosition>145</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270393</mtid>
          <link>/api/reference/44270393</link>
          <label>146. Xu, F., Astragaloside IV inhibits lung cancer progression and metastasis by modulating macrophage polarization through AMPK signaling (2018) J. Exp. Clin. Cancer Res., 37 (1), p. 207</label>
          <listPosition>146</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270394</mtid>
          <link>/api/reference/44270394</link>
          <label>147. Hu, S., Zheng, W., Jin, L., Astragaloside IV inhibits cell proliferation and metastasis of breast cancer via promoting the long noncoding RNA TRHDE-AS1 (2021) J. Nat. Med., 75 (1), pp. 156-166</label>
          <listPosition>147</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270395</mtid>
          <link>/api/reference/44270395</link>
          <label>148. He, Y., Astragaloside IV enhanced carboplatin sensitivity in prostate cancer by suppressing AKT/NF-κB signaling pathway (2021) Biochem. Cell. Biol., 99 (2), pp. 214-222</label>
          <listPosition>148</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270396</mtid>
          <link>/api/reference/44270396</link>
          <label>149. Lai, S.T., Wang, Y., Peng, F., Astragaloside IV sensitizes non-small cell lung cancer cells to cisplatin by suppressing endoplasmic reticulum stress and autophagy (2020) J. Thorac. Dis., 12 (7), pp. 3715-3724</label>
          <listPosition>149</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270397</mtid>
          <link>/api/reference/44270397</link>
          <label>150. Alotaibi, M.R., A newly synthesized platinum-based compound (PBC-II) increases chemosensitivity of HeLa ovarian cancer cells via inhibition of autophagy (2019) Saudi Pharmaceut. J., 27 (8), pp. 1203-1209</label>
          <listPosition>150</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270398</mtid>
          <link>/api/reference/44270398</link>
          <label>151. Cournoyer, S., GX15-070 (Obatoclax), a Bcl-2 family proteins inhibitor engenders apoptosis and pro-survival autophagy and increases Chemosensitivity in neuroblastoma (2019) BMC Cancer, 19 (1), p. 1018</label>
          <listPosition>151</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270399</mtid>
          <link>/api/reference/44270399</link>
          <label>152. Chen, M.S., Flavopereirine inhibits autophagy via the AKT/p38 MAPK signaling pathway in MDA-MB-231 cells (2020) Int. J. Mol. Sci., 21 (15)</label>
          <listPosition>152</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270400</mtid>
          <link>/api/reference/44270400</link>
          <label>153. Lin, C.Y., Chen, Y.H., Huang, Y.C., Hesperetin induces autophagy and delayed apoptosis by modulating the AMPK/Akt/mTOR pathway in human leukemia cells in vitro (2023) Curr. Issues Mol. Biol., 45 (2), pp. 1587-1600</label>
          <listPosition>153</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270401</mtid>
          <link>/api/reference/44270401</link>
          <label>154. Wu, R., Baicalein targets GTPase-mediated autophagy to eliminate liver tumor-initiating stem cell-like cells resistant to mTORC1 inhibition (2018) Hepatology, 68 (5), pp. 1726-1740</label>
          <listPosition>154</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270402</mtid>
          <link>/api/reference/44270402</link>
          <label>155. Zhan, Y., The novel autophagy inhibitor alpha-Hederin promoted paclitaxel cytotoxicity by increasing reactive oxygen species accumulation in non-small cell lung cancer cells (2018) Int. J. Mol. Sci., 19 (10)</label>
          <listPosition>155</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270403</mtid>
          <link>/api/reference/44270403</link>
          <label>156. Chen, J., CUR5g, a novel autophagy inhibitor, exhibits potent synergistic anticancer effects with cisplatin against non-small-cell lung cancer (2022) Cell Death Dis., 8 (1), p. 435</label>
          <listPosition>156</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270404</mtid>
          <link>/api/reference/44270404</link>
          <label>157. Liao, M., Autophagy blockade by ai du qing formula promotes chemosensitivity of breast cancer stem cells via GRP78/β-catenin/ABCG2 Axis (2021) Front. Pharmacol., 12</label>
          <listPosition>157</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270405</mtid>
          <link>/api/reference/44270405</link>
          <label>158. Hwang, J.R., Chloroquine reverses chemoresistance via upregulation of p21(WAF1/CIP1) and autophagy inhibition in ovarian cancer (2020) Cell Death Dis., 11 (12), p. 1034</label>
          <listPosition>158</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270406</mtid>
          <link>/api/reference/44270406</link>
          <label>159. He, R., Alantolactone induces apoptosis and improves chemosensitivity of pancreatic cancer cells by impairment of autophagy-lysosome pathway via targeting TFEB (2018) Toxicol. Appl. Pharmacol., 356, pp. 159-171</label>
          <listPosition>159</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270407</mtid>
          <link>/api/reference/44270407</link>
          <label>160. Mirzaei, S., Employing siRNA tool and its delivery platforms in suppressing cisplatin resistance: approaching to a new era of cancer chemotherapy (2021) Life Sci., 277</label>
          <listPosition>160</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270408</mtid>
          <link>/api/reference/44270408</link>
          <label>161. Mirzaei, S., Small interfering RNA (siRNA) to target genes and molecular pathways in glioblastoma therapy: current status with an emphasis on delivery systems (2021) Life Sci., 275</label>
          <listPosition>161</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270409</mtid>
          <link>/api/reference/44270409</link>
          <label>162. Ashrafizadeh, M., Biomedical application of chitosan-based nanoscale delivery systems: potential usefulness in siRNA delivery for cancer therapy (2021) Carbohydrate Polym., 260</label>
          <listPosition>162</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270410</mtid>
          <link>/api/reference/44270410</link>
          <label>163. Wang, J., Curcumol synergizes with cisplatin in osteosarcoma by inhibiting M2-like polarization of tumor-associated macrophages (2022) Molecules, 27 (14)</label>
          <listPosition>163</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270411</mtid>
          <link>/api/reference/44270411</link>
          <label>164. Guo, J., Hypoxia induces chemoresistance to proteasome inhibitors through orchestrating deSUMOylation and ubiquitination of SRC-3 in multiple myeloma (2022) Oncogene, 41 (45), pp. 4971-4979</label>
          <listPosition>164</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270412</mtid>
          <link>/api/reference/44270412</link>
          <label>165. Li, H., Hypoxia upregulates the expression of lncRNA H19 in non-small cell lung cancer cells and induces drug resistance (2022) Transl. Cancer Res., 11 (8), pp. 2876-2886</label>
          <listPosition>165</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270413</mtid>
          <link>/api/reference/44270413</link>
          <label>166. Cheng, F.Y., The oxygen-generating calcium peroxide-modified magnetic nanoparticles attenuate hypoxia-induced chemoresistance in triple-negative breast cancer (2021) Cancers, 13 (4)</label>
          <listPosition>166</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270414</mtid>
          <link>/api/reference/44270414</link>
          <label>167. Zhao, L., Co-delivery of Gefitinib and chloroquine by chitosan nanoparticles for overcoming the drug acquired resistance (2015) J. Nanobiotechnol., 13, p. 57</label>
          <listPosition>167</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270415</mtid>
          <link>/api/reference/44270415</link>
          <label>168. Shi, C., Co-delivery of docetaxel and chloroquine via PEO-PPO-PCL/TPGS micelles for overcoming multidrug resistance (2015) Int. J. Pharm., 495 (2), pp. 932-939</label>
          <listPosition>168</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270416</mtid>
          <link>/api/reference/44270416</link>
          <label>169. Ashrafizadeh, M., Progress in delivery of siRNA-based therapeutics employing nano-vehicles for treatment of prostate cancer (2020) Bioengineering, 7 (3), p. 91</label>
          <listPosition>169</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270417</mtid>
          <link>/api/reference/44270417</link>
          <label>170. Ashrafizadeh, M., Progress in natural compounds/siRNA co-delivery employing nanovehicles for cancer therapy (2020) ACS Comb. Sci., 22 (12), pp. 669-700</label>
          <listPosition>170</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270418</mtid>
          <link>/api/reference/44270418</link>
          <label>171. Yang, B., Hao, A., Chen, L., Mirror siRNAs loading for dual delivery of doxorubicin and autophagy regulation siRNA for multidrug reversing chemotherapy (2020) Biomed. Pharmacother., 130</label>
          <listPosition>171</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270419</mtid>
          <link>/api/reference/44270419</link>
          <label>172. Hu, C., Co-delivery of the autophagy inhibitor si-Beclin1 and the doxorubicin nano-delivery system for advanced prostate cancer treatment (2022) J. Biomater. Appl., 36 (7), pp. 1317-1331</label>
          <listPosition>172</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270420</mtid>
          <link>/api/reference/44270420</link>
          <label>173. Kulkarni, B., Exosome-mediated delivery of miR-30a sensitize cisplatin-resistant variant of oral squamous carcinoma cells via modulating Beclin1 and Bcl2 (2020) Oncotarget, 11 (20), pp. 1832-1845</label>
          <listPosition>173</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270421</mtid>
          <link>/api/reference/44270421</link>
          <label>174. Wang, J., Qiu, L., Drug-induced self-assembled nanovesicles for doxorubicin resistance reversal via autophagy inhibition and delivery synchronism (2022) Theranostics, 12 (8), pp. 3977-3994</label>
          <listPosition>174</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270422</mtid>
          <link>/api/reference/44270422</link>
          <label>175. Saiyin, W., Sequential release of autophagy inhibitor and chemotherapeutic drug with polymeric delivery system for oral squamous cell carcinoma therapy (2014) Mol. Pharm., 11 (5), pp. 1662-1675</label>
          <listPosition>175</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270423</mtid>
          <link>/api/reference/44270423</link>
          <label>176. Zhang, M., Delivery of siRNA using functionalized gold nanorods enhances anti-osteosarcoma efficacy (2021) Front. Pharmacol., 12</label>
          <listPosition>176</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270424</mtid>
          <link>/api/reference/44270424</link>
          <label>177. Gao, M., Xu, Y., Qiu, L., Enhanced combination therapy effect on paclitaxel-resistant carcinoma by chloroquine co-delivery via liposomes (2015) Int. J. Nanomed., 10, pp. 6615-6632</label>
          <listPosition>177</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270425</mtid>
          <link>/api/reference/44270425</link>
          <label>178. Lin, Y.X., Reactivation of the tumor suppressor PTEN by mRNA nanoparticles enhances antitumor immunity in preclinical models (2021) Sci. Transl. Med., 13 (599)</label>
          <listPosition>178</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270426</mtid>
          <link>/api/reference/44270426</link>
          <label>179. Qiao, H., Surmounting tumor resistance to metallodrugs by co-loading a metal complex and siRNA in nanoparticles (2021) Chem. Sci., 12 (12), pp. 4547-4556</label>
          <listPosition>179</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270427</mtid>
          <link>/api/reference/44270427</link>
          <label>180. Wu, X., Co-loaded lapatinib/PAB by ferritin nanoparticles eliminated ECM-detached cluster cells via modulating EGFR in triple-negative breast cancer (2022) Cell Death Dis., 13 (6), p. 557</label>
          <listPosition>180</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270428</mtid>
          <link>/api/reference/44270428</link>
          <label>181. Miao, Y.H., Zinc oxide nanoparticles reduce the chemoresistance of gastric cancer by inhibiting autophagy (2021) World J. Gastroenterol., 27 (25), pp. 3851-3862</label>
          <listPosition>181</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270429</mtid>
          <link>/api/reference/44270429</link>
          <label>182. Zheng, Y., mAb MDR1-modified chitosan nanoparticles overcome acquired EGFR-TKI resistance through two potential therapeutic targets modulation of MDR1 and autophagy (2017) J. Nanobiotechnol., 15 (1), p. 66</label>
          <listPosition>182</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270430</mtid>
          <link>/api/reference/44270430</link>
          <label>183. Wang, Y., Brucea javanica oil emulsion promotes autophagy in ovarian cancer cells through the miR-8485/LAMTOR3/mTOR/ATG13 signaling Axis (2022) Front. Pharmacol., 13</label>
          <listPosition>183</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270431</mtid>
          <link>/api/reference/44270431</link>
          <label>184. Ahmadpour, F., Methylation-mediated silencing of miR-125a-5p facilitates breast cancer progression by inducing autophagy (2022) Mol. Biol. Rep., 49 (7), pp. 6325-6339</label>
          <listPosition>184</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270432</mtid>
          <link>/api/reference/44270432</link>
          <label>185. Li, X., MiR-1298-5p level downregulation induced by Helicobacter pylori infection inhibits autophagy and promotes gastric cancer development by targeting MAP2K6 (2022) Cell. Signal., 93</label>
          <listPosition>185</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270433</mtid>
          <link>/api/reference/44270433</link>
          <label>186. Li, H., MicroRNA-20a-5p inhibits the autophagy and cisplatin resistance in ovarian cancer via regulating DNMT3B-mediated DNA methylation of RBP1 (2022) Reprod. Toxicol., 109, pp. 93-100</label>
          <listPosition>186</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270434</mtid>
          <link>/api/reference/44270434</link>
          <label>187. Bollaert, E., MiR-15a-5p confers chemoresistance in acute myeloid leukemia by inhibiting autophagy induced by daunorubicin (2021) Int. J. Mol. Sci., 22 (10)</label>
          <listPosition>187</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270435</mtid>
          <link>/api/reference/44270435</link>
          <label>188. Wang, J., MKNK2 enhances chemoresistance of ovarian cancer by suppressing autophagy via miR-125b (2021) Biochem. Biophys. Res. Commun., 556, pp. 31-38</label>
          <listPosition>188</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270436</mtid>
          <link>/api/reference/44270436</link>
          <label>189. Liu, W., TRIM22 inhibits osteosarcoma progression through destabilizing NRF2 and thus activation of ROS/AMPK/mTOR/autophagy signaling (2022) Redox Biol., 53</label>
          <listPosition>189</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270437</mtid>
          <link>/api/reference/44270437</link>
          <label>190. Zhan, F., SAR1A regulates the RhoA/YAP and autophagy signaling pathways to influence osteosarcoma invasion and metastasis (2022) Cancer Sci., 113 (12), pp. 4104-4119</label>
          <listPosition>190</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270438</mtid>
          <link>/api/reference/44270438</link>
          <label>191. Gao, S., Wang, K., Wang, X., miR-375 targeting autophagy-related 2B (ATG2B) suppresses autophagy and tumorigenesis in cisplatin-resistant osteosarcoma cells (2020) Neoplasma, 67 (4), pp. 724-734</label>
          <listPosition>191</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270439</mtid>
          <link>/api/reference/44270439</link>
          <label>192. Li, Y., miR-199a-5p represses protective autophagy and overcomes chemoresistance by directly targeting DRAM1 in acute myeloid leukemia (2019) JAMA Oncol., 2019</label>
          <listPosition>192</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270440</mtid>
          <link>/api/reference/44270440</link>
          <label>193. Entezari, M., Long non-coding RNAs and exosomal lncRNAs: potential functions in lung cancer progression, drug resistance and tumor microenvironment remodeling (2022) Biomed. Pharmacother., 150</label>
          <listPosition>193</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270441</mtid>
          <link>/api/reference/44270441</link>
          <label>194. Ashrafizadeh, M., Long noncoding RNAs (lncRNAs) in pancreatic cancer progression (2022) Drug Discov. Today, 27 (8), pp. 2181-2198</label>
          <listPosition>194</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270442</mtid>
          <link>/api/reference/44270442</link>
          <label>195. Luo, Y., Long noncoding RNA (lncRNA) EIF3J-DT induces chemoresistance of gastric cancer via autophagy activation (2021) Autophagy, 17 (12), pp. 4083-4101</label>
          <listPosition>195</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270443</mtid>
          <link>/api/reference/44270443</link>
          <label>196. Dai, H., LncRNA OIP5-AS1 promotes the autophagy-related imatinib resistance in chronic myeloid leukemia cells by regulating miR-30e-5p/ATG12 Axis (2021) Technol. Cancer Res. Treat., 20</label>
          <listPosition>196</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270444</mtid>
          <link>/api/reference/44270444</link>
          <label>197. Zhu, K., LncRNA Sox2OT-V7 promotes doxorubicin-induced autophagy and chemoresistance in osteosarcoma via tumor-suppressive miR-142/miR-22 (2020) Aging (Albany NY), 12 (8), pp. 6644-6666</label>
          <listPosition>197</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270445</mtid>
          <link>/api/reference/44270445</link>
          <label>198. Zhang, J., LncRNA-HOTAIR activates autophagy and promotes the imatinib resistance of gastrointestinal stromal tumor cells through a mechanism involving the miR-130a/ATG2B pathway (2021) Cell Death Dis., 12 (4), p. 367</label>
          <listPosition>198</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270446</mtid>
          <link>/api/reference/44270446</link>
          <label>199. Patop, I.L., Wüst, S., Kadener, S., Past, present, and future of circRNAs (2019) EMBO J., 38 (16)</label>
          <listPosition>199</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270447</mtid>
          <link>/api/reference/44270447</link>
          <label>200. Duan, X., Yu, X., Li, Z., Circular RNA hsa_circ_0001658 regulates apoptosis and autophagy in gastric cancer through microRNA-182/Ras-related protein Rab-10 signaling axis (2022) Bioengineered, 13 (2), pp. 2387-2397</label>
          <listPosition>200</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270448</mtid>
          <link>/api/reference/44270448</link>
          <label>201. Yan, L., Hsa_circ_0035483 sponges hsa-miR-335 to promote the gemcitabine-resistance of human renal cancer cells by autophagy regulation (2019) Biochem. Biophys. Res. Commun., 519 (1), pp. 172-178</label>
          <listPosition>201</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270449</mtid>
          <link>/api/reference/44270449</link>
          <label>202. Wang, Q., Hsa_circ_0092276 promotes doxorubicin resistance in breast cancer cells by regulating autophagy via miR-348/ATG7 axis (2021) Transl Oncol, 14 (8)</label>
          <listPosition>202</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270450</mtid>
          <link>/api/reference/44270450</link>
          <label>203. Fang, L., Circular CPM promotes chemoresistance of gastric cancer via activating PRKAA2-mediated autophagy (2022) Clin. Transl. Med., 12 (1), p. e708</label>
          <listPosition>203</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270451</mtid>
          <link>/api/reference/44270451</link>
          <label>204. Li, L., Circ_100565 promotes proliferation, migration and invasion in non-small cell lung cancer through upregulating HMGA2 via sponging miR-506-3p (2020) Cancer Cell Int., 20, p. 160</label>
          <listPosition>204</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270452</mtid>
          <link>/api/reference/44270452</link>
          <label>205. Zhong, Y., CircRNA_100565 contributes to cisplatin resistance of NSCLC cells by regulating proliferation, apoptosis and autophagy via miR-337-3p/ADAM28 axis (2021) Cancer Biomarkers, 30 (2), pp. 261-273</label>
          <listPosition>205</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270453</mtid>
          <link>/api/reference/44270453</link>
          <label>206. Paskeh, M.D.A., Emerging role of exosomes in cancer progression and tumor microenvironment remodeling (2022) J. Hematol. Oncol., 15 (1), p. 83</label>
          <listPosition>206</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270454</mtid>
          <link>/api/reference/44270454</link>
          <label>207. Chen, Y., Exosomal circ_0091741 promotes gastric cancer cell autophagy and chemoresistance via the miR-330-3p/TRIM14/Dvl2/Wnt/β-catenin axis (2023) Hum. Cell, 36 (1), pp. 258-275</label>
          <listPosition>207</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270455</mtid>
          <link>/api/reference/44270455</link>
          <label>208. Huang, F.X., LncRNA BLACAT1 is involved in chemoresistance of non-small cell lung cancer cells by regulating autophagy (2019) Int. J. Oncol., 54 (1), pp. 339-347</label>
          <listPosition>208</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270456</mtid>
          <link>/api/reference/44270456</link>
          <label>209. Xin, R., Oncogenic lncRNA MALAT-1 recruits E2F1 to upregulate RAD51 expression and thus promotes cell autophagy and tumor growth in non-small cell lung cancer (2023) Pulm. Pharmacol. Ther.</label>
          <listPosition>209</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270457</mtid>
          <link>/api/reference/44270457</link>
          <label>210. Fei, D., LncRNA FGD5-AS1 potentiates autophagy-associated doxorubicin resistance by regulating the miR-154-5p/WNT5A axis in osteosarcoma (2022) Cell Biol. Int., 46 (11), pp. 1937-1946</label>
          <listPosition>210</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270458</mtid>
          <link>/api/reference/44270458</link>
          <label>211. Duan, B., Zhang, H., Zhu, Z., Yan, X., Ji, Z., (2023), pp. 10-97. , J. Li.LncRNA LINC01871 sponging miR-142-3p to modulate ZYG11B promotes the chemoresistance of colorectal cancer cells by inducing autophagyAnti Cancer Drugs (20)</label>
          <listPosition>211</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270459</mtid>
          <link>/api/reference/44270459</link>
          <label>212. Xia, C., Insulin-like growth factor 2 mRNA-binding protein 2-stabilized long non-coding RNA Taurine up-regulated gene 1 (TUG1) promotes cisplatin-resistance of colorectal cancer via modulating autophagy (2022) Bioengineered, 13 (2), pp. 2450-2469</label>
          <listPosition>212</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270460</mtid>
          <link>/api/reference/44270460</link>
          <label>213. Pan, X., Knockdown of TRIM65 inhibits autophagy and cisplatin resistance in A549/DDP cells by regulating miR-138-5p/ATG7 (2019) Cell Death Dis., 10 (6), p. 429</label>
          <listPosition>213</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270461</mtid>
          <link>/api/reference/44270461</link>
          <label>214. Gao, W., circPARD3 drives malignant progression and chemoresistance of laryngeal squamous cell carcinoma by inhibiting autophagy through the PRKCI-Akt-mTOR pathway (2020) Mol. Cancer, 19 (1), p. 166</label>
          <listPosition>214</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270462</mtid>
          <link>/api/reference/44270462</link>
          <label>215. Zhou, Y., miR-223 overexpression inhibits doxorubicin-induced autophagy by targeting FOXO3a and reverses chemoresistance in hepatocellular carcinoma cells (2019) Cell Death Dis., 10 (11), p. 843</label>
          <listPosition>215</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270463</mtid>
          <link>/api/reference/44270463</link>
          <label>216. Ueda, S., miR-27a ameliorates chemoresistance of breast cancer cells by disruption of reactive oxygen species homeostasis and impairment of autophagy (2020) Lab. Invest., 100 (6), pp. 863-873</label>
          <listPosition>216</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270464</mtid>
          <link>/api/reference/44270464</link>
          <label>217. Huang, S., The HIF-1α/miR-224-3p/ATG5 axis affects cell mobility and chemosensitivity by regulating hypoxia-induced protective autophagy in glioblastoma and astrocytoma (2019) Oncol. Rep., 41 (3), pp. 1759-1768</label>
          <listPosition>217</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270465</mtid>
          <link>/api/reference/44270465</link>
          <label>218. Ma, Y., Exosomal transfer of cisplatin-induced miR-425-3p confers cisplatin resistance in NSCLC through activating autophagy (2019) Int. J. Nanomed., 14, pp. 8121-8132</label>
          <listPosition>218</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270466</mtid>
          <link>/api/reference/44270466</link>
          <label>219. Yang, S., MicroRNA-375 targets ATG14 to inhibit autophagy and sensitize hepatocellular carcinoma cells to sorafenib (2020) OncoTargets Ther., 13, pp. 3557-3570</label>
          <listPosition>219</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270467</mtid>
          <link>/api/reference/44270467</link>
          <label>220. Wang, H., MiR-223 regulates autophagy associated with cisplatin resistance by targeting FBXW7 in human non-small cell lung cancer (2020) Cancer Cell Int., 20, p. 258</label>
          <listPosition>220</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270468</mtid>
          <link>/api/reference/44270468</link>
          <label>221. Zhao, L., ATF4-mediated microRNA-145/HDAC4/p53 axis affects resistance of colorectal cancer cells to 5-fluorouracil by regulating autophagy (2022) Cancer Chemother. Pharmacol., 89 (5), pp. 595-607</label>
          <listPosition>221</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270469</mtid>
          <link>/api/reference/44270469</link>
          <label>222. Zhang, Y., circHIPK3 promotes oxaliplatin-resistance in colorectal cancer through autophagy by sponging miR-637 (2019) EBioMedicine, 48, pp. 277-288</label>
          <listPosition>222</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270470</mtid>
          <link>/api/reference/44270470</link>
          <label>223. Kong, R., Circular RNA hsa_circ_0085131 is involved in cisplatin-resistance of non-small-cell lung cancer cells by regulating autophagy (2020) Cell Biol. Int., 44 (9), pp. 1945-1956</label>
          <listPosition>223</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270471</mtid>
          <link>/api/reference/44270471</link>
          <label>224. Győrffy, B., Discovery and ranking of the most robust prognostic biomarkers in serous ovarian cancer (2023) Geroscience</label>
          <listPosition>224</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270472</mtid>
          <link>/api/reference/44270472</link>
          <label>225. Li, Q., Jetset: selecting the optimal microarray probe set to represent a gene (2011) BMC Bioinf., 12, p. 474</label>
          <listPosition>225</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>44270473</mtid>
          <link>/api/reference/44270473</link>
          <label>226. Hansen, A.R., Pantoprazole affecting docetaxel resistance pathways via autophagy (PANDORA): phase II trial of high dose pantoprazole (autophagy inhibitor) with docetaxel in metastatic castration-resistant prostate cancer (mCRPC) (2019) Oncol., 24 (9), pp. 1188-1194</label>
          <listPosition>226</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
      </references>
      <link>/api/publication/34093130</link>
      <label>Qin Y. et al. Autophagy and cancer drug resistance in dialogue: Pre-clinical and clinical evidence. (2023) CANCER LETTERS 0304-3835 1872-7980 570</label><template>&lt;div class=&quot;JournalArticle Publication short-list&quot;&gt; &lt;div class=&quot;authors&quot;&gt; &lt;span class=&quot;author-name&quot; &gt; Qin, Y. ✉ &lt;/span&gt; &lt;span class=&quot;author-type&quot;&gt; &lt;/span&gt; ; &lt;span class=&quot;author-name&quot; &gt; Ashrafizadeh, M. ✉ &lt;/span&gt; &lt;span class=&quot;author-type&quot;&gt; &lt;/span&gt; ; &lt;span class=&quot;author-name&quot; &gt; Mongiardini, V. &lt;/span&gt; &lt;span class=&quot;author-type&quot;&gt; &lt;/span&gt; ; &lt;span class=&quot;author-name&quot; &gt; Grimaldi, B. &lt;/span&gt; &lt;span class=&quot;author-type&quot;&gt; &lt;/span&gt; ; &lt;span class=&quot;author-name&quot; &gt; Crea, F. &lt;/span&gt; &lt;span class=&quot;author-type&quot;&gt; &lt;/span&gt; ; &lt;span class=&quot;author-name&quot; &gt; Rietdorf, K. &lt;/span&gt; &lt;span class=&quot;author-type&quot;&gt; &lt;/span&gt; ; &lt;span class=&quot;author-name&quot; mtid=&quot;10000109&quot;&gt; &lt;a href=&quot;/gui2/?type=authors&amp;mode=browse&amp;sel=10000109&quot; target=&quot;_blank&quot;&gt;Győrffy, B.&lt;/a&gt; &lt;/span&gt; &lt;span class=&quot;author-type&quot;&gt; &lt;/span&gt; ; &lt;span class=&quot;author-name&quot; &gt; Klionsky, D.J. &lt;/span&gt; &lt;span class=&quot;author-type&quot;&gt; &lt;/span&gt; ; &lt;span class=&quot;author-name&quot; &gt; Ren, J. &lt;/span&gt; &lt;span class=&quot;author-type&quot;&gt; &lt;/span&gt; ; &lt;span class=&quot;author-name&quot; &gt; Zhang, W. &lt;/span&gt; &lt;span class=&quot;author-type&quot;&gt; &lt;/span&gt; et al. &lt;/div &gt;&lt;div class=&quot;title&quot;&gt;&lt;a href=&quot;/gui2/?mode=browse&amp;params=publication;34093130&quot; mtid=&quot;34093130&quot; target=&quot;_blank&quot;&gt;Autophagy and cancer drug resistance in dialogue: Pre-clinical and clinical evidence&lt;/a&gt;&lt;/div&gt; &lt;div class=&quot;pub-info&quot;&gt; &lt;span class=&quot;journal-title&quot;&gt;CANCER LETTERS&lt;/span&gt; &lt;span class=&quot;journal-volume&quot;&gt;570&lt;/span&gt; &lt;span class=&quot;page&quot;&gt; Paper: 216307 , 15 p. &lt;/span&gt; &lt;span class=&quot;year&quot;&gt;(2023)&lt;/span&gt; &lt;/div&gt; &lt;div class=&quot;pub-end&quot;&gt;&lt;div class=&quot;identifier-list&quot;&gt; &lt;span class=&quot;identifiers&quot;&gt; &lt;span class=&quot;id identifier oa_PAY&quot; title=&quot; Pay &quot;&gt; &lt;a style=&quot;color:blue&quot; title=&quot;10.1016/j.canlet.2023.216307&quot; target=&quot;_blank&quot; href=&quot;https://doi.org/10.1016/j.canlet.2023.216307&quot;&gt; DOI &lt;/a&gt; &lt;/span&gt; &lt;span class=&quot;id identifier oa_none&quot; title=&quot;none&quot;&gt; &lt;a style=&quot;color:blue&quot; title=&quot;001056616500001&quot; target=&quot;_blank&quot; href=&quot;https://www.webofscience.com/wos/woscc/full-record/001056616500001&quot;&gt; WoS &lt;/a&gt; &lt;/span&gt; &lt;span class=&quot;id identifier oa_none&quot; title=&quot;none&quot;&gt; &lt;a style=&quot;color:blue&quot; title=&quot;85166563267&quot; target=&quot;_blank&quot; href=&quot;http://www.scopus.com/record/display.url?origin=inward&amp;eid=2-s2.0-85166563267&quot;&gt; Scopus &lt;/a&gt; &lt;/span&gt; &lt;span class=&quot;id identifier oa_none&quot; title=&quot;none&quot;&gt; &lt;a style=&quot;color:blue&quot; title=&quot;37451426&quot; target=&quot;_blank&quot; href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=37451426&amp;dopt=Abstract&quot;&gt; PubMed &lt;/a&gt; &lt;/span&gt; &lt;/span&gt; &lt;/div&gt; &lt;div class=&quot;short-pub-prop-list&quot;&gt; &lt;span class=&quot;deleted-record&quot;&gt;Centrally managed&lt;/span&gt; &lt;span class=&quot;short-pub-mtid&quot;&gt; Publication:34093130 &lt;/span&gt; &lt;span class=&quot;status-holder&quot;&gt;&lt;span class=&quot;status-data status-VALIDATED&quot;&gt; Validated &lt;/span&gt;&lt;/span&gt; &lt;span class=&quot;pub-core&quot;&gt;Core Citing &lt;/span&gt; &lt;span class=&quot;pub-type&quot;&gt;Journal Article (Article ) &lt;/span&gt; &lt;!-- &amp;&amp; !record.category.scientific --&gt; &lt;span class=&quot;pub-category&quot;&gt;Scientific&lt;/span&gt; &lt;div class=&quot;publication-citation&quot; style=&quot;margin-left: 0.5cm;&quot;&gt; &lt;span title=&quot;&quot; class=&quot;citingPub-count&quot;&gt;Citing papers: 195&lt;/span&gt; | Independent citation: 174 | Self citation: 21 | Unknown citation: 0 | Number of citations in WoS: 177 | Number of citations in Scopus:&amp;nbsp;177 | WoS/Scopus assigned:&amp;nbsp;195 | Number of citations with DOI:&amp;nbsp;194 &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;</template><template2>&lt;div class=&quot;JournalArticle Publication long-list&quot;&gt;
&lt;div class=&quot;authors&quot;&gt;
	&lt;img title=&quot;Forrásközlemény&quot; style=&quot;float: left&quot; src=&quot;/frontend/resources/grid/publication-core-icon.png&quot;&gt;
	&lt;img title=&quot;Idézőközlemény&quot; style=&quot;float: left&quot; src=&quot;/frontend/resources/grid/publication-citation-icon.png&quot;&gt;

		&lt;div class=&quot;autype autype0&quot;&gt;				&lt;span class=&quot;author-name&quot; &gt;Qin Y. ✉
    &lt;/span&gt;
;&amp;nbsp;&amp;nbsp;&amp;nbsp;
							&lt;span class=&quot;author-name&quot; &gt;Ashrafizadeh M. ✉
    &lt;/span&gt;
;&amp;nbsp;&amp;nbsp;&amp;nbsp;
							&lt;span class=&quot;author-name&quot; &gt;Mongiardini V.
    &lt;/span&gt;
;&amp;nbsp;&amp;nbsp;&amp;nbsp;
							&lt;span class=&quot;author-name&quot; &gt;Grimaldi B.
    &lt;/span&gt;
;&amp;nbsp;&amp;nbsp;&amp;nbsp;
							&lt;span class=&quot;author-name&quot; &gt;Crea F.
    &lt;/span&gt;
;&amp;nbsp;&amp;nbsp;&amp;nbsp;
							&lt;span class=&quot;author-name&quot; &gt;Rietdorf K.
    &lt;/span&gt;
;&amp;nbsp;&amp;nbsp;&amp;nbsp;
							&lt;span class=&quot;author-name&quot; mtid=&quot;10000109&quot;&gt;&lt;a 
																				   href=&quot;/gui2/?type=authors&amp;mode=browse&amp;sel=10000109&quot; target=&quot;_blank&quot;&gt;Győrffy B.
            (&lt;span class=&quot;authorship-author-name&quot;&gt;Győrffy Balázs&lt;/span&gt;
            &lt;span class=&quot;authorAux-mtmt&quot;&gt; Onkológia&lt;/span&gt;)
			&lt;/a&gt;
    &lt;/span&gt;
&lt;span class=&quot;author-affil&quot;&gt;&lt;span title=&quot;Research Centre for Natural Sciences&quot;&gt;RCNS&lt;/span&gt;/&lt;span title=&quot;Institute of Molecular Life Sciences&quot;&gt;IMLS&lt;/span&gt;/Enzim_417; &lt;span title=&quot;Semmelweis University&quot;&gt;SU&lt;/span&gt;/&lt;span title=&quot;Faculty of Medicine&quot;&gt;FM&lt;/span&gt;/&lt;span title=&quot;Instituties&quot;&gt;I&lt;/span&gt;/Bioinformatika Tanszék; &lt;span title=&quot;Semmelweis University&quot;&gt;SU&lt;/span&gt;/&lt;span title=&quot;Faculty of Medicine&quot;&gt;FM&lt;/span&gt;/&lt;span title=&quot;Clinical&quot;&gt;C&lt;/span&gt;/Department of Pediatrics&lt;/span&gt;
;&amp;nbsp;&amp;nbsp;&amp;nbsp;
							&lt;span class=&quot;author-name&quot; &gt;Klionsky D.J.
    &lt;/span&gt;
;&amp;nbsp;&amp;nbsp;&amp;nbsp;
							&lt;span class=&quot;author-name&quot; &gt;Ren J.
    &lt;/span&gt;
;&amp;nbsp;&amp;nbsp;&amp;nbsp;
							&lt;span class=&quot;author-name&quot; &gt;Zhang W.
    &lt;/span&gt;
;&amp;nbsp;&amp;nbsp;&amp;nbsp;
							&lt;span class=&quot;author-name&quot; &gt;Zhang X. ✉
    &lt;/span&gt;

				    &lt;/div&gt;
&lt;/div&gt;
&lt;div class=&quot;title&quot;&gt;&lt;a href=&quot;/gui2/?mode=browse&amp;params=publication;34093130&quot; target=&quot;_blank&quot;&gt;Autophagy and cancer drug resistance in dialogue: Pre-clinical and clinical evidence&lt;/a&gt;&lt;/div&gt;    &lt;div&gt;		&lt;span class=&quot;journal-title&quot;&gt;CANCER LETTERS&lt;/span&gt;

        &lt;span class=&quot;journal-issn&quot;&gt;(&lt;a target=&quot;_blank&quot; href=&quot;https://portal.issn.org/resource/ISSN/0304-3835&quot;&gt;0304-3835&lt;/a&gt; &lt;a target=&quot;_blank&quot; href=&quot;https://portal.issn.org/resource/ISSN/1872-7980&quot;&gt;1872-7980&lt;/a&gt;)&lt;/span&gt;:
		&lt;span class=&quot;journal-volume&quot;&gt;570&lt;/span&gt; 
&lt;span class=&quot;page&quot;&gt;
		Paper 216307.
	 15 p. 
&lt;/span&gt;		 &lt;span class=&quot;year&quot;&gt;(2023)&lt;/span&gt;  
    &lt;/div&gt;
&lt;div class=&quot;pub-footer&quot;&gt;
    

	&lt;span class=&quot;language&quot; xmlns=&quot;http://www.w3.org/1999/html&quot;&gt;Language:
			English
		 |  &lt;/span&gt;

	&lt;span class=&quot;identifiers&quot;&gt;
						&lt;span class=&quot;id identifier oa_PAY&quot; title=&quot;	Pay
&quot;&gt;
							
							&lt;a style=&quot;color:blue&quot; title=&quot;10.1016/j.canlet.2023.216307&quot; target=&quot;_blank&quot; href=&quot;https://doi.org/10.1016/j.canlet.2023.216307&quot;&gt;
									DOI
							&lt;/a&gt;
						&lt;/span&gt;
						&lt;span class=&quot;id identifier oa_none&quot; title=&quot;none&quot;&gt;
							
							&lt;a style=&quot;color:blue&quot; title=&quot;001056616500001&quot; target=&quot;_blank&quot; href=&quot;https://www.webofscience.com/wos/woscc/full-record/001056616500001&quot;&gt;
									WoS
							&lt;/a&gt;
						&lt;/span&gt;
						&lt;span class=&quot;id identifier oa_none&quot; title=&quot;none&quot;&gt;
							
							&lt;a style=&quot;color:blue&quot; title=&quot;85166563267&quot; target=&quot;_blank&quot; href=&quot;http://www.scopus.com/record/display.url?origin=inward&amp;eid=2-s2.0-85166563267&quot;&gt;
									Scopus
							&lt;/a&gt;
						&lt;/span&gt;
						&lt;span class=&quot;id identifier oa_none&quot; title=&quot;none&quot;&gt;
							
							&lt;a style=&quot;color:blue&quot; title=&quot;37451426&quot; target=&quot;_blank&quot; href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=37451426&amp;dopt=Abstract&quot;&gt;
									PubMed
							&lt;/a&gt;
						&lt;/span&gt;
	&lt;/span&gt;


	&lt;OnlyViewableByAuthor&gt;&lt;div class=&quot;ratings&quot;&gt;
				&lt;div class=&quot;journal-subject&quot;&gt;Journal subject: Scopus - Oncology&amp;nbsp;&amp;nbsp;&amp;nbsp;Rank:&amp;nbsp;D1&lt;/div&gt;
				&lt;div class=&quot;journal-subject&quot;&gt;Journal subject: Scopus - Cancer Research&amp;nbsp;&amp;nbsp;&amp;nbsp;Rank:&amp;nbsp;Q1&lt;/div&gt;
    &lt;/div&gt;&lt;/OnlyViewableByAuthor&gt;


	&lt;div class=&quot;publication-citation&quot; style=&quot;margin-left: 0.5cm;&quot;&gt;
		&lt;span title=&quot;&quot; class=&quot;citingPub-count&quot;&gt;Citing papers: 195&lt;/span&gt;
		| Independent citation: 174
		| Self citation: 21
		| Unknown citation: 0
		| Number of citations in WoS: 177 
		|  Number of citations in Scopus:&amp;nbsp;177 
		|  WoS/Scopus assigned:&amp;nbsp;195 
		|  Number of citations with DOI:&amp;nbsp;194 
		
	&lt;/div&gt;
    
    
	&lt;div class=&quot;publication-citation&quot;&gt;
		&lt;a target=&quot;_blank&quot; href=&quot;/api/publication?cond=citations.related;eq;34093130&amp;sort=publishedYear,desc&amp;sort=title&quot;&gt;
			Number of cited publications: 4
		&lt;/a&gt;
	&lt;/div&gt;



    &lt;div class=&quot;mtid&quot;&gt;&lt;span class=&quot;long-pub-mtid&quot;&gt;Publication: 34093130&lt;/span&gt;
    | &lt;span class=&quot;status-data status-VALIDATED&quot;&gt; 	Validated
  &lt;/span&gt;
        
	
	
Core	 Citing
	
	
    | &lt;span class=&quot;type-subtype&quot;&gt;Journal Article
			( Article
			
			)
		&lt;/span&gt;
      		| &lt;span class=&quot;pub-category&quot;&gt;Scientific&lt;/span&gt;
	| &lt;span class=&quot;publication-sourceOfData&quot;&gt;Scopus&lt;/span&gt;
&lt;/div&gt;


&lt;div class=&quot;lastModified&quot;&gt;Last Modified: 2023.09.28. 13:48 Kinga Sonnevend (SE_AOK_Adm5_Élet_kutcsop, admin)
&lt;/div&gt;


        &lt;div class=&quot;lockedBy&quot;&gt;Centrally managed 2024.04.04. 12:41  Andrea Vándor (VA, admin)
        &lt;/div&gt;


	&lt;pre class=&quot;comment&quot; style=&quot;margin-top: 0; margin-bottom: 0;&quot;&gt;&lt;u&gt;Comments&lt;/u&gt;: Department of Lab, Chifeng Cancer Hospital (The 2nd Affliated Hospital of Chifeng University), Chifeng University, Inner Mongolia Autonomous Region, Chifeng City, 024000, China            
            Department of General Surgery and Institute of Precision Diagnosis and Treatment of Digestive System Tumors, Carson International Cancer Center, Shenzhen University General Hospital, Shenzhen Univ...&lt;/pre&gt;
&lt;/div&gt;&lt;/div&gt;</template2>
    </publication>
  </content>
</myciteResult>
